Abstract
Since the surge of microbiome research in the last decade, many studies have provided insight into the causes and consequences of changes in the gut microbiota. Among the multiple factors involved in regulating the microbiome, exogenous factors such as diet and environmental chemicals have been shown to alter the gut microbiome significantly. Although diet substantially contributes to changes in the gut microbiome, environmental chemicals are major contaminants in our food and are often overlooked. Herein, we summarize the current knowledge on major classes of environmental chemicals (bisphenols, phthalates, persistent organic pollutants, heavy metals, and pesticides) and their impact on the gut microbiome, which includes alterations in microbial composition, gene expression, function, and health effects in the host. We then discuss health-related implications of gut microbial changes, which include changes in metabolism, immunity, and neurological function.
Keywords: environmental chemicals, gut microbiome, health risks
Humans are exposed to hundreds of chemicals as evidenced by the fact that more than 300 environmental chemicals or their metabolites have been measured in human biological samples (CDC, 2017). Human exposure to these environmental chemicals is constant, and some of these chemicals have long half-lives in the body and environment. Chemicals such as bisphenols, phthalates, pesticides, persistent organic pollutants (POPs), and heavy metals have endocrine-disrupting effects that can alter hormonal metabolism. Many of these environmental chemicals are associated with adverse health outcomes, including male and female reproductive and developmental defects, type 2 diabetes, cardiovascular dysfunction, liver disease, obesity, thyroid disorders, and immune dysfunction (Chiang and Flaws, 2019; Hannon and Flaws, 2015; Jaishankar et al., 2014; Nagy et al., 2019; Rochester, 2013). The gut microbiome influences host metabolism, and thus, it may mediate some of the toxic effects of environmental chemicals (Martin et al., 2019). With chronic exposure to a variety of environmental chemicals, it is vital to understand how the gut microbial community changes in response to environmental chemical exposures and the implications of such changes on health outcomes.
In this review, we summarize the known impact of environmental chemical exposure on the gut microbiome, with a specific focus on the effects of bisphenols, phthalates, POPs, heavy metals, and pesticides on the gut microbiome. These chemical classes were included in the review because exposure to these chemicals is frequent in humans, and increasing evidence suggests they alter gut microbiota composition. In addition to summarizing the impact of these chemicals on altering the gut microbiome, we also summarize alterations in gene expression, functional changes, and health implications associated with these gut microbiome changes.
BISPHENOLS AND THE GUT MICROBIOME
Bisphenol A (BPA), a plastic monomer and high-volume industrial chemical, is one of the most widely studied endocrine-disrupting chemicals. Extensive research has shown that BPA is a reproductive toxicant, a neurotoxicant, and an obesogen, likely due to its affinity to multiple hormone receptors in the body (Patisaul, 2020; Vom Saal et al., 2012; Ziv-Gal and Flaws, 2016).
Recent animal studies of developmental and adult exposure to BPA demonstrate that BPA can alter the gut microbiota of a variety of species in a sex-specific manner (Table 1). For example, male mice exposed to BPA have increased Prevotellaceae (Javurek et al., 2016), bacteria that are known to be involved in the mucosal barrier function (Wright et al., 2000). However, female mice have no change in the relative abundance of Prevotellaceae (Javurek et al., 2016). BPA exposure also upregulated the levels of Akkermansia and Methanobrevibacter in the gut microbiome of males. This is of concern because Akkermansia, which plays a role in butyrate production, is also elevated in human cancers (Baxter et al., 2014; Weir et al., 2013), implying that BPA-induced gut microbiome alterations may increase the risk of carcinogenesis. However, other species of Akkermansia have been shown to be beneficial for intestinal immunity, glucose metabolism, and lipid metabolism (Naito et al., 2018). Furthermore, Methanobrevibacter is shown to heighten the host’s ability to metabolize exogenous fuels, resulting in upregulated host energy intake and weight gain (Samuel and Gordon, 2006; Sweeney and Morton, 2013). This raises a strong possibility that BPA-induced weight gain is caused at least partially by BPA-induced changes in the gut microbiome. Overall, BPA exposure produces sex-specific outcomes on the gut microbiome, implying that BPA-exposed males and females may be at different risk for certain diseases.
Table 1.
Chemical | Exposure Window | Dose | Model | Sex & Sex Differences | Effect on Gut Microbiota | Conclusions | References |
---|---|---|---|---|---|---|---|
BPA | Developmental | 0, 0.2, 0.6, 1.7, 2.9, 5.7, 11.5, 23.0, or 45.0 µM in water environment | Zebrafish embryo | Not applicable |
|
|
Catron et al. (2019) |
50 µg/kg bw dams dosed orally from GD 15 to weaning | Mice | Male offspring |
|
|
Malaise et al. (2017) | ||
50 µg/kg bw dams dosed orally from GD 15 to weaning | Mice | Female offspring | Not applicable |
|
Malaise et al. (2018) | ||
200 µg/kg bw dams dosed orally from GD 15 to PND 7 | Rabbits | Male offspring |
|
|
Reddivari et al. (2017) | ||
50 mg/kg feed weight (approximately 10mg/kg bw) F0 dams exposed through chow 2 weeks before mating through PND 30 (weaning), F0 males exposed breeding through weaning | Mice | Both; yes |
|
|
Javurek et al. (2016) | ||
Juvenile | 30 µg/kg BW gavaged from PND 28 to 56 | Nonobese diabetic mice | Female |
|
|
Xu et al. (2019) | |
Adult | 0, 2, and 20 µg/L and 2 or 20 µg/L BPA + 100 µg/l nano-TiO2 in water environment for 3 months | Zebrafish | Both; yes |
|
|
Chen et al. (2018b) | |
12–18 µg/kg feed weight in dog food contaminated with BPA can lining, 14 days | Dogs, gonadectomized | Both; yes but small n |
|
|
Koestel et al. (2017) | ||
2000 µg/L in water environment for 5 weeks | Zebrafish | Male, age not specified | BPA altered microbial community; no analysis of statistical significance between groups |
|
Liu et al. (2017) | ||
In vitro | 0–400 µM for 24 h | HCT116 human colon cancer cells | Not applicable | Not applicable |
|
Qu et al. (2018) | |
25, 250, and 2500 µg/L in nutritional medium for 10 days | In vitro Simulator of the Human Intestinal Microbial Ecosystem | Not applicable |
|
|
Wang et al. (2018b) | ||
0–400 µM for 24 h | LS174T human colonic goblet cells | Not applicable | Not applicable |
|
Zhao et al. (2018) | ||
Other bisphenols | Developmental | BPAF (0, 0.2, 0.6, 1.8, 5.2, 15.3, or 45.0 µM), BPB (0, 0.6, 1.7, 5.1, 15.0, or 44.0 µM), BPF (0, 0.2, 0.6, 1.8, 5.2, 15.3, 45.0 µM), BPS (0, 0.2, 0.6, 1.8, 5.2, 15.3, 45.0 µM) in water environment for 10 days | Zebrafish embryo | Not applicable |
|
|
Catron et al. (2019) |
In support of the disease-driving effect of BPA exposure, studies found that BPA-induced alterations in gut microbiota are often associated with several physiological disorders in the host (Table 1). BPA-induced microbial alterations are found to increase oxidative stress, which is a trigger to inflammation. In vitro studies with human colonic cell lines show increased oxidative stress in response to BPA treatment (Qu et al., 2018; Zhao et al., 2019). A study using the in vitro Simulator of the Human Intestinal Microbial Ecosystem (SHIME) system to predict the effects of BPA on the human gut also found increased expression of genes related to oxidative stress (Wang et al., 2018b). Furthermore, developmental BPA exposure in mice and rabbits reduced the diversity of gut microbiota composition with a decrease in protective bacteria, such as short-chain fatty acid (SCFA) producers. This is accompanied by chronic intestinal and hepatic inflammation and metabolic disorder (Malaise et al., 2017, 2018; Reddivari et al., 2017). The mechanisms by which BPA executes its actions on the gut microbiome remain unclear. Interestingly, in comparison with the effects of the synthetic estrogen ethinylestradiol (EE), BPA caused many of the same microbial effects as EE on the gut, such as decreased relative abundance of Firmicutes and Proteobacteria, implying BPA may modify gut microbiota through an estrogenic mechanism (Javurek et al., 2016, Liu et al., 2016).
In addition to the effect on the gut, BPA treatment is known to affect brain development, behavior, and lipid and glucose metabolism (Collins et al., 2012; Guan et al., 2019; Nicholson et al., 2012). As gut microbiota function is known to be important for both brain and metabolic health, it is tempting to speculate that BPA-induced gut microbiome alterations partially mediate the adverse effects of BPA on neurological and metabolic health. Although BPA studies reveal a strong effect of this chemical on altering gut microbiota composition (Catron et al., 2019; Javurek et al., 2016; Wang et al., 2018b), studies that evaluate the contribution of such alterations to BPA-induced adverse neurological and metabolic health outcomes are critically needed.
Because the problematic endocrine disrupting properties of BPA have come to light, alternative bisphenols have increased in prevalence and use (Rochester and Bolden, 2015). Considerably less research has been performed on alternative bisphenols, despite that fact that some may be more developmentally toxic than BPA (Kinch et al., 2015). A study examining the effects of bisphenol S (BPS), bisphenol F (BPF), bisphenol B (BPB), bisphenol AF (BPAF), as well as BPA on the gut microbiome in zebrafish embryos found that the least developmentally toxic bisphenols (BPA, BPS, and BPF) had the most substantial impacts on the microbial community (Catron et al., 2019). In contrast, the most developmentally toxic bisphenols (BPB and BPAF) did not impact microbiota (Catron et al., 2019). The observed developmental toxicity ranking mirrors bisphenol potency in estrogen receptor activation in vitro, implying a causal relationship between estrogenicity and microbiota disruption. Future studies should determine the effects of other bisphenol alternatives, such as BPS, BPF, BPB, and BPAF, on the gut microbiome using mouse or pig models for human research and examine if they lead to similar outcomes in mammals. Furthermore, more studies are needed to determine the mechanism by which the changes in the gut microbiome lead to neurological and metabolic health defects.
PHTHALATES AND THE GUT MICROBIOME
Phthalates are plasticizers and stabilizers found in vinyl flooring, clothing, detergents, personal care products, children’s toys, medical equipment, and plastic packaging film (Babich and Osterhout, 2010; Wittassek et al., 2011). Phthalates are commonly found in the environment as phthalate vapors or dust particles, but they are also found in food and beverages. Because phthalates are noncovalently bound to materials, they can easily leach into the environment. As a result, foodstuff is the primary source of phthalate exposure. Besides ingestion, other routes of exposure to phthalates include inhalation, dermal absorption, and intravenous exposure.
Recent studies in several species indicate that developmental phthalate exposure alters gut microbiota composition and may have significant health consequences (Table 2). Humans exposed to high levels of phthalates at birth (commonly through intravenous infusions) have altered gut microbiota, and these changes have been associated with enhanced immunoglobulin M responses against hepatitis B vaccine vaccination, suggesting that phthalate-induced gut microbial changes in early life may alter immune responses to vaccination (Yang et al., 2019b). Mono-(2-ethylhexyl) phthalate (MEHP) exposure in pubertal mice shifts the gut microbiota composition, and this was accompanied by adipocyte hypertrophy and cholesterol overloading (Wang et al., 2019a), implying a causal relationship between MEHP-induced gut microbiota changes and impaired lipid metabolism. Subchronic exposure to di-2-ethylhexyl phthalate (DEHP) in female mice enhanced the production of p-cresol, which inhibits the synthesis of butyrate (Lei et al., 2019). Given that butyrate is a microbial metabolite essential for intestinal homeostasis (Parada Venegas et al., 2019), immune regulation (Correa-Oliveira et al., 2016), and neurological function (Bourassa et al., 2016), exposure to DEHP may lead to intestinal defects, immune dysfunction, and neurobehavioral impairments. The known effects of phthalates on gut microbiota in humans, rodents, and aquatic fishes are summarized in Table 2. Future studies should continue to examine whether phthalate exposure alters the gut microbiome via microbiome sequencing. In addition to sequencing studies, future studies should determine which gut microbes degrade phthalates and inoculate a single strain of bacteria into gnotobiotic animals to determine the function of that microbe.
Table 2.
Chemical | Exposure Window | Dose | Model | Sex & Sex Differences | Effect on Gut Microbiota | Conclusions | References |
---|---|---|---|---|---|---|---|
DEHP | Birth | Newborns who did not receive intravenous infusion (control) vs newborns with respiratory distress who were given intravenous infusions | Newborn infants | Both sexes were used; however, sex differences were not assessed as both sexes were combined for analyses | ↓ Rothia spp. and Bifidobacterium longum |
|
Yang et al. (2019b) |
DEP, methylparaben, triclosan | From birth to PND 62 and 191 | 0.1735, 0.105, and 0.05 mg/kg/day | Sprague Dawley rats | Female |
|
|
Hu et al. (2016) |
MEHP | 4-week exposure starting at puberty (4 weeks old) | 0 or 0.05 mg/kg MEHP with normal diet or high-fat diet | 4-week-old C57Bl/6 mice | Male |
|
|
Wang et al. (2019a) |
DEHP | Pubertal exposure for 7 and 14 days | 0,1, or 10 mg/kg/day (oral gavage every other day)0, 10, or 100 µM DEHP in cecal contents (in vitro) | 6- to 8-week-old C57Bl/6 mice | Female |
|
|
Lei et al. (2019) |
DMP, DEP, and DBP combined | Not Available | 500 mg/l | Asian carp species silver (Hypophthalmichthys molitrix) and bighead (Hypophthalmichthys Nobilis) | Not applicable | Achromobacter aegrifaciens, Pseudomonas japonica, Bacillus subtilis, and Pseudomonas putida isolated and enriched |
|
Kolb et al. (2019) |
Abbreviations: DBP, dibutyl phthalate; DEHP, di-2-ethylhexyl phthalate; DEP, diethyl phthalate; DMP, dimethyl phthalate; MEHP, mono-(2-ethylhexyl) phthalate.
POPs AND THE GUT MICROBIOME
Persistent organic pollutants are organic chemicals that contain hydrophobic and lipophilic properties and can be carried long distances through the air and water. Because these toxic chemicals are resistant to environmental degradation, POPs and their by-products can biomagnify and bioaccumulate in the ecosystem. Few POPs occur naturally in the environment. Instead, most POPs are synthesized for agricultural and industrial use, such as pesticides/insecticides, fast-food packaging, nonstick coatings for cookware, and heat exchange fluids.
Accumulating evidence indicates that POPs are toxic to human health and are linked to reproductive disorders, neurobehavioral impairments, and immune dysfunction (Li et al., 2006; Siwen et al., 2013). With increasing recognition of the roles of the gut microbiota on the immune system and knowing that the gut is the largest immune organ, recent studies have begun to investigate the impact of POP exposure on the gut microbiota and the potential roles it may have on health and disease. Specifically, these studies have investigated the impact of POP exposure on the gut microbiota during the developmental, juvenile, and adult stages in a variety of animals, including mice, fish, and humans (Table 3). In this section, we discuss highly studied POPs, including polychlorinated biphenyls (PCBs), polycyclic aromatic hydrocarbons (PAHs), perfluorochemicals (PFCs), and polybrominated diphenyl ethers (PBDEs), polychlorinated dibenzo-p-dioxins (PCDDs), and the impact these chemicals have on the gut microbiome.
Table 3.
Chemical | Exposure Window | Dose | Model | Sex & Sex Differences | Effect on Gut Microbiota | Conclusions | References |
---|---|---|---|---|---|---|---|
PCB mixture | Developmental | 0, 0.1, 1, or 6 mg/kg/day starting 2 weeks before gestation and continuing through PND 21 |
|
No sex effects were observed, so all the data are combined and represented as equal proportions of males and females |
|
|
Rude et al. (2019) |
PCB-126 | Adult, 7 weeks old | 0 or 1 µmol/kg/day at weeks 2 and 4 | Ldlr−/− mice | Male |
|
|
Petriello et al. (2018) |
Atrazine, estradiol, PCB126, PCB153 | Adult (4 months) | DMSO or 1.0 µg/l of environmental pollutant mixture | Zebrafish |
|
↑ Aeromonas in females |
|
Chen et al. (2018b) |
PCB congeners (PCB153, PCB138, PCB180) | Adults 11–13 months of age | Exercise for 5 days followed by 2 days of oral exposure to PCB mixture (150 µmol/kg) | C57Bl/6J mice | Males |
|
|
Choi et al. (2013) |
PAH parent compounds: naphthalene, phenanthrene, pyrene, and benzo(a)pyrene | In vitro | 62.5 nmol | In vitro SHIME | Not applicable | Not specified |
|
Van de Wiele et al. (2005) |
PAH | Information not available | No exposure to oil (northern Norway area) or 0.01 ppm exposure to oil (southern Norway area) | Atlantic cod (Gadus Morhua) | Not applicable | Clean water fish: Fusobacteria and Proteobacteria were the most abundant, followed by Firmicutes and Bacteroidetes. Fish exposed to oil-contaminated waters showed dominance in Firmicutes, followed by Proteobacteria, Bacteroidetes, and Fusobacteria. Vibrionales was the most abundant order identified |
|
Walter et al. (2019) |
PFBS | In utero exposure (eggs exposed to PFBS) | 0, 1.0, 2.9, 9.5 µg/l for the entire lifecycle | Marine medaka |
|
Intestines of F0-exposed males:
|
|
Chen et al. (2018a) |
PFAS: F-53B | Adult, 6 weeks old | 0, 1, 3, or 10 µg/l for 10 weeks | C57Bl/6 mice |
|
|
|
Pan et al. (2019) |
BDE-47 | In utero and lactational exposure | 0, 0.002, and 0.2 mg/kg BDE-47 from GD 6 to PND 21. Male mice selected to be either on normal diet or HFD for 14 weeks | Primigravida female ICR mice | Only male mice were selected for analysis |
|
|
Wang et al. (2018a) |
BDE-47 or BDE-99 | Adult, 9 weeks old | 0 or 100 µmol/kg/day for 4 days | C57Bl/6 mice (conventional and germ-free) | Males | PBDE exposure altered 23 gut microbial taxa |
|
Scoville et al. (2019) |
OBS | Adult, 6 weeks old | 0, 0.1, 1, or 10 µg/l | ICR mice | Males | Not applicable |
|
Wang et al. (2019b) |
HCH | Adult | N/A | Mothers-humans | Males and females were combined for analyses, so sex differences were not determined |
|
|
Tang et al. (2019) |
Endosulfan | Adult, 8 weeks old | 0, 0.5, or 3.5 mg/kg/day for 2 weeks | ICR mice | Male | Not applicable |
|
Zhang et al. (2017) |
TCDD | Juvenile, 4 weeks old | 0 or 30 µg/kg/day every 4 days for 28 days | Gnotobiotic C57Bl/6 | Female | ↑ Segmented filamentous bacteria (SFB)↓ Bacteroides fragilis |
|
Stedtfeld et al. (2017b) |
TCDD | Juvenile, PND 28, 29 | 0–30 µg/kg/day for 28 and 92 days with the latter having a 30-day recovery period | C57Bl/6 mice | Female | ↑ Enterobacteriaceae |
|
Stedtfeld et al. (2017c) |
TCDD | Adult, 5–8 weeks old | 0, 0.1, 1.0, and 10 µg/kg/day for 4 days | B6C3F1 mice | Female | Expression of SFB in mouse ileum |
|
Stedtfeld et al. (2017a) |
TCDD | Adult, 6 and 7 weeks old | 0 or 6 µg/kg biweekly for 26 weeks | CD-1 mice in a prediabetic hyperglycemic state via streptozotocin intraperitoneal injection | Male |
|
|
Lefever et al. (2016) |
TCDD, PhIP, HBD, B[a]P, deltamethrin, and PAHs | Adults | 0.005, 0.90, 2.60, 5, 21, and 38 µg/ml |
|
Not applicable | Not applicable |
|
Defois et al. (2018) |
TCDF | Adult (8 weeks old) | 0 or 24 µg/kg/day for 5 days | C57Bl/6J mice | Males |
|
|
Zhang et al. (2015a) |
Abbreviations: α-HBCD, α-hexabromocyclododecane; γ-HBCD, γ-hexabromocyclododecane; BDE-47, 2,2′,4,4′-tratrabromodiphenyl ether; DMSO, dimethyl sulfoxide; F-53B, 6:2 chlorinated polyfluorinated ether sulfonate; FXR, farnesoid X receptor; HCH, hexachlorocyclohexane; OBS, sodium p-perfluorous nonenoxybenzene sulfonate; PAH, polycyclic aromatic hydrocarbons; PBDE, polybrominated diphenyl ether; PCB, polychlorinated biphenyls; PFAS, per- and polyfluoroalkylated substances; PFBS, perfluorobutane sulfonate; SCFA, short-chain fatty acid; SHIME, Simulator of the Human Intestinal Microbial Ecosystem; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; TCDF, 2,3,7,8-tetrachloro dibenzofuran.
Polychlorinated Biphenyls
Polychlorinated biphenyls were commercially used in thermal insulation materials, floor finishes, and electrical equipment before being banned in 1979 in the United States. However, PCBs persist in the environment and contaminate the food supply. Therefore, a primary route of exposure is by ingestion of PCBs. Developmental exposure to PCBs in the maternal diet significantly increased gut permeability and immune factors (Il6) in the murine ileum compared with control (Rude et al., 2019). Gene expression of inflammatory markers (Il6, IL1β, and IL22) in the colon was also increased in PCB-exposed mice compared with control (Rude et al., 2019). In addition to these functional changes in gastrointestinal (GI) physiology and immunology, PCB exposure markedly decreased the relative abundance of Proteobacteria, Bacteroidales family S7-25, and Alistipes compared with control (Rude et al., 2019). These findings support that PCB exposure impacts GI physiology, modifies the gut microbiota composition, and alters mucosal immune responses.
In adult male mice, exposure to PCB-126 reduced cecal α-diversity and increased the Firmicutes to Bacteroidetes ratio (F/B ratio) (Petriello et al., 2018). High F/B ratio has been observed in adult, obese populations in mice (Ley et al., 2005) and humans (Ley et al., 2006), implying that PCB-126 exposure may increase the risk of developing obesity. However, associations between the gut microbiome, specifically F/B ratio, and obesity are uncertain as Sze and collaborators revisited and reanalyzed 10 studies and determined that the association between F/B ratio and obesity was relatively weak (Sze and Schloss, 2016). Upon further analysis, the studies included in their analyses had small sample sizes and large interpersonal variation (Sze and Schloss, 2016). PCB exposure also increased intestinal inflammation as demonstrated by increased hepcidin (Hemp) and Tnfa in the colon and Il-6 and Il-18 in the jejunum (Petriello et al., 2018). Furthermore, research in fish indicates that PCB-induced intestinal microbiota changes involve aryl hydrocarbon receptor (AhR) signaling (Chen et al., 2018b; Gao et al., 2018b; Ji and Qu, 2019).
Interestingly, a few studies suggest that the effect of PCBs on gut microbiota may be age-dependent. Acute PCB exposure in aging mice (11–13 months) decreased the relative abundance of Proteobacteria phyla (Choi et al., 2013). This is in contrast to the effects of PCB exposure during development exposure through the maternal diet, which increased Proteobacteria (Rude et al., 2019). It is important to note that the exposure methods in the studies were slightly different, which is a limitation. However, it is known that the gut microbiome changes with age (Cresci and Bawden, 2015).
Recently, a study identified that it is possible to attenuate PCB-induced gut microbiota changes in mice through exercise (Choi et al., 2013). However, more studies are needed to address and provide solutions on how to attenuate or prevent PCB-induced gut microbiota changes that are associated with increased gut permeability, intestinal inflammation, and cognitive dysfunction.
Polycyclic Aromatic Hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are naturally found in the environment and are generated when burning wood, oil, and gas. Compared with PCBs, not many studies have investigated the impact of PAHs on the gut microbiota. One study used the in vitro SHIME system to show that PAH exposure in the colonic microbiome biotransforms PAHs to acquire more estrogenic activity than the parent compounds (Van de Wiele et al., 2005). Although these estrogenic metabolites have similar estrogenicity equivalent to 0.31–2.70 nmol 17α-ethynylestradiol (EE2), further examination needs to be conducted on the actual PAH metabolites. A study in Atlantic cod exposed to PAH-contaminated waters showed different microbial communities compared with Atlantic cod residing in uncontaminated waters. PAH-exposed Atlantic cod contains PAH-degrading bacteria such as Novosphingobium, Sphingobium, and Sphingomonas, which are not present in unexposed Atlantic cod (Walter et al., 2019). More studies are needed in models such as mice or rats to determine if these changes also occur in mammals and how we can attenuate the changes in the gut microbiome.
Perfluorochemicals
Perfluorochemicals are commercially used in nonstick cookware, food packaging, and stain-resistant carpets. Although little is known about the impact of perfluorochemicals on the gut microbiome, a few studies have examined per- and polyfluoroalkylated substance (PFAS) and per- and polyfluorobutane substance (PFBS) exposure in utero and during adult stages of life (Table 3). Male fish exposed to PFBS (0, 1.0, 2.9, 9.5 µg/l) had an increased abundance of Cetobacterium compared with control male fish. The increase in Cetobacterium was positively correlated with altered tight junction protein expression, a marker of epithelial barrier integrity (Chen et al., 2018a). In addition to experiencing alteration of gut microbiota composition and expression of tight junction proteins, males had hyperactive inflammatory responses (Chen et al., 2018a). In contrast to males, PFBS-treated female fish only had slightly increased inflammatory responses, but had severely impaired lipid metabolism as demonstrated by their decreased levels of triglycerides and free fatty acids (Chen et al., 2018a). The alteration in gut microbiota in fertile adults persisted in the offspring. These offspring had increased mortality, especially at higher doses of exposure compared with controls (Chen et al., 2018a). These data suggest that PFC exposure alters the gut microbiome in a sex-dependent manner in fish, and this comes with sex-dependent health outcomes. In addition, the data suggest that gut microbiota alterations and the adverse effects on gut homeostasis, such as increased inflammation, upregulated oxidative stress, and a compromised intestinal epithelial barrier, can be carried over to the next generation.
Unfortunately, there are conflicting results on whether the results observed in fish are translatable to mammals such as mice. PFBS exposure in mouse adipose cells showed that triglyceride levels were increased compared with control (Qi et al., 2018). In contrast, PFC exposure, specifically perfluorooctanesulfonic acid (PFOS) exposure, increased triglyceride levels in mice, whereas PFC exposure, specifically PFBS, decreased triglyceride levels in fish (Wang et al., 2015). Major reasons for these conflicting results include the use of distinct models and species, different PFCs, and research performed outside a living organism versus within a living organism. Another limitation of the study on PFBS exposure is that fish were not exposed to environmentally relevant doses (Chen et al., 2018a). The study used doses in the µg/l range (0, 1, 2.9, and 9.5 µg/l) (Chen et al., 2018a). European adults are exposed to 0.03–3.72 ng/kg/day PFBS (EFSA, 2012; EPA, 2018), and Americans are exposed to roughly 4.2 ng/ml PFBS (Olsen et al., 2017). Although the study in fish did not use environmentally relevant doses, it is still beneficial to study high doses above relevant exposures because these chemicals can bioaccumulate in the body.
Chlorinated polyfluorinated ether sulfonate or F-53B/(6:2) is another perfluorochemical commonly used in electroplating wastewater in China (Siwen et al., 2013). F-53B exposure in adult mice decreased the abundance of Firmicutes and increased the abundance of Verrucomicrobia in both male and female mice (Pan et al., 2019). F-53B exposure also caused sex-specific responses in the gut microbiota. For example, treated male mice had a significant increase in Akkermansia compared with control male mice, but treatment did not cause any variation in female mice. Treated female mice had a significant decrease in Parabacteroides compared with control female mice, but this did not occur in male mice (Wang et al., 2019c). In addition to sex-specific gut microbial deviations, both male and female mice had significantly decreased mucus production and gene expression of ion transporters at the highest dose of F-53B exposure (Pan et al., 2019). The potential link between these changes and gut microbiome alterations remain unclear. The different responses of the gut microbiome in males and females to F-53B exposure may explain sex differences in the effects of F-53B exposure on health outcomes.
Polybrominated Diphenyl Ethers
BDE-47 and BDE-99 are 2 PBDEs commonly used as flame retardants in building materials, furniture, airplanes, polyurethane foams, and electronics. Exposure to PBDEs in utero and adulthood perturbs the gut microbiome. Specifically, BDE-47 exposure in utero and during lactation reduced diversity of gut microbiota composition and impaired glucose homeostasis in male mice (Wang et al., 2018a). In adult male mice, BDE-47 and BDE-99 exposure altered 23 gut microbial taxa and amino acid and carbohydrate metabolism (Scoville et al., 2019). Specifically, BDE-treated mice had decreased branched-chain and aromatic amino acid metabolites compared with controls. Although these previous studies provide important information, they both used male mice only. It is important to study the female sex as well and compare that to the male sex because males and females have different hormone profiles, which can affect the impact of environmental chemicals on the entire body, including the gastrointestinal and reproductive tracts. Overall, these studies indicate that exposure to PBDEs can alter gut microbiome and impair metabolism. It would be interesting to know if PBDE-induced gut microbiome alterations mediate some aspects of the metabolic disorders in PBDEs-treated animal models.
Polychlorinated Dibenzo-p-Dioxins
Polychlorinated dibenzo-p-dioxins are naturally formed from volcanic eruptions and forest fires. However, human activities create the most dioxins by manufacturing pesticides and burning organic materials, such as fossil fuels and garbage. Exposure to dioxins can occur through inhalation, ingestion, and dermal absorption. Two dioxins that have been studied are 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,3,7,8-tetrachlorodibenzofuran (TCDF).
In a series of studies carried out by the same laboratory, conventional, and gnotobiotic female mice were orally dosed with vehicle control or TCDD to assess the effects of TCDD on the gut microbiota (Stedtfeld et al., 2017a,b,c). In the first study, conventional female mice treated with TCDD showed increased Enterobacteriaceae compared with control mice (Stedtfeld et al., 2017c). Gut microbiota alterations due to TCDD treatment were associated with an increase in the reservoir of antibiotic-resistant genes in the gut microbiome. In a second study, gnotobiotic mice of the same sex (female) were colonized with and without segmented filamentous bacteria (SFB) and polysaccharide A (Stedtfeld et al., 2017b). SFB is an immune activator, whereas polysaccharide A is a background immune suppressor. TCDD treatment increased SFB and decreased Bacteroides fragilis compared with control. Thus, the TCDD-induced host response was significantly impacted by the presence of SFB in the gut microbiome (Stedtfeld et al., 2017b). The addition of activated carbon decreased the bioavailability of TCDD and obliterated the expression of the SFB 16S rRNA gene (Stedtfeld et al., 2017a). Activated carbon had minimal influences on the murine gut microbiome and affected the relative abundance of Lactobacillaceae and 2 other minor groups. TCDD exposure had drastic effects on the gut microbiome, and activated carbon attenuated the changes in the gut microbiome (Stedtfeld et al., 2017a). Altogether, these studies indicate that TCDD causes alterations in the gut microbiota, which are associated with antibiotic resistance; however, the presence of activated carbon reduces TCDD exposure and possibly antibiotic resistance.
Chronic TCDD exposure in adult male mice also caused alterations in gut microbiota. The dysregulation in the gut microbiome may have contributed to immune toxicities, and this aligns with several studies that examined the effects of TCDD on immune responses. An in vitro study cultured human fecal suspensions with TCDD. Following TCDD-gut microbiota interaction, fecal suspensions were processed for its cellular supernatant and incubated with intestinal epithelial cells to measure immune responses (Defois et al., 2018). TCDF exposure increased IL-8 secretion from intestinal epithelial cells, suggesting that dioxin disturbance may promote inflammation and is immunotoxic (Zhang et al., 2015a). Beyond associative changes in gut microbiome with the immune system, changes in the gut microbiota due to TCDD exposure link to liver toxicity as there were marked increases in bile acids and SCFAs and decreases in farnesoid X receptor signaling (Wang et al., 2019b; Zhang et al., 2017). Ultimately, these studies suggest that dioxin exposure disrupts both gut microbiome and lipid and glucose metabolism. Whether there is a causal relationship between dioxin-induced alterations in gut microbiome and metabolic disorder remains to be studied.
HEAVY METALS AND THE GUT MICROBIOME
Heavy metals are natural, high-density elements found in the Earth’s crust and are highly toxic even at low concentrations. Like POPs, heavy metals bioaccumulate in some organisms and further increase the burden of heavy metals. Several studies have examined the impact of heavy metals, such as lead, cadmium, arsenic, and mercury on the gut microbiome (Table 4). In mice, lead exposure reduced diversity of gut microbiota and altered the metabolism of many pathways, including vitamin E, bile acid, and nitrogen metabolism (Gao et al., 2017c).
Table 4.
Chemical | Exposure Window | Dose | Model | Sex & Sex Differences | Effect on Gut Microbiota | Conclusions | References |
---|---|---|---|---|---|---|---|
Lead | Perinatal | 32 ppm until 40 weeks of age in maternal drinking water | Mice |
|
Bacteroidetes and Firmicutes shifted in response to Pb exposure |
|
Wu et al. (2016) |
Lead | Juvenile (6 weeks old) | 100 and 500 ppm for 8 weeks in drinking water | Balb/c mice | Female |
|
|
Breton et al. (2013) |
Lead | Adult, 7 weeks old | 10 ppm for 13 weeks in drinking water | C57Bl/6 mice | Female |
|
|
Gao et al. (2017c) |
Cadmium | Larval stage | 0, 5, 100, and 200 µg/l from Gosner stage 26 to 38 | Bufo gargarizans larvae | Not specified |
|
|
Ya et al. (2019) |
Cadmium | Juvenile | 0, 50, and 500 µg Cd/l in drinking water for 4 weeks | Cyprinus carpio | Not applicable |
|
|
Chang et al. (2019) |
Cadmium | Juvenile (5 weeks old) | 10 ppm in drinking water for 10 weeks | C57Bl/6 mice | Male |
|
|
Zhang et al. (2015b) |
Cadmium | Juvenile (6 weeks old) | 20 and 100 ppm for 8 weeks in drinking water | Balb/c mice | Female |
|
|
Breton et al. (2013) |
Arsenic | Neonatal (PND 10) | 0.05 mg/kg bw | CD-1 mice | Female |
|
|
Gokulan et al. (2018) |
Arsenic and zinc | Juvenile | Zinc restriction and 0, 50, 500 ppb inorganic arsenic in drinking water for 6 weeks | C57BL/6 mice | Female |
|
|
Gaulke et al. (2018) |
Arsenic | Juvenile | 100 ppb for 13 weeks | C57Bl/6 mice | Female |
|
|
Chi et al. (2017) |
Arsenic | Juvenile (5 weeks old) | 3 mg/l As, 5 mg/l Fe + 3 mg/l As, and 5 mg/l Fe | ICR mice | Male |
|
|
Guo et al. (2014) |
Arsenic | Juvenile (5 weeks old) | 50 ppm in drinking water for 2 weeks | C57Bl/6 mice | Not specified | ↓ Gut microbiota diversity but not significant |
|
Li et al. (2019b) |
Arsenic | Juvenile to adult (6–8 weeks old) | 0, 10, or 250 ppb arsenite As(III) for 2, 5, or 10 weeks | C57Bl/6 Tac mice | Male |
|
|
Dheer et al. (2015) |
Arsenic | Adult, 7 weeks old | 0, 250 ppb, and 1 ppm in drinking water | C57Bl/6 mice (with normal or disrupted gut microbiome) | Female | Not applicable |
|
Chi et al. (2019) |
Arsenic | Adult, 8 weeks old | 0 or 10 ppm for 4 weeks | C57Bl/6 mice | Female |
|
|
Lu et al. (2014a) |
Arsenic | Adult, 9 and 10 weeks old | 0 or 10 ppm in drinking water for 4 weeks | C57Bl/6 mice (free of Helicobacter) | Not specified | Not applicable |
|
Xue et al. (2019) |
Arsenic | Adult, 8 weeks old | 0 or 10 ppm in drinking water for 4 weeks | C57Bl/6 mice, WT and IL10−/− | Females |
|
|
Lu et al. (2014b) |
Arsenic | Adult, 8 weeks old | 10 ppm in drinking water for 4 weeks | C57Bl/6 mice |
|
Female-treated mice:
|
|
Chi et al. (2016) |
Arsenic | Adult, 7–13 weeks old | 0, 25, or 100 ppm inorganic arsenic in drinking water for 2 weeks | Germ-free C57Bl/6 WT and AS3MT-KO mice | Male and female were combined for the analyses; therefore, sex differences were not determined | Presence of Faecalibacterium prausnitzii suggest this microbe provides protection by decreasing arsenic toxicity increasing butyrate synthesis |
|
Coryell et al. (2018) |
Arsenic | 25- to 50-year-old adults | Not applicable | Humans | Male and female adults were included in the study but sex differences were not determined | Did not identify associations between arsenic exposure and the composition of the gut microbiome after correcting for multiple testing |
|
Wu et al. (2019) |
Methylmercury (MeHg) | Adult, 4 weeks old | 0 or 10 µg/kg bw (oral dosing) | Sprague Dawley rats | Male |
|
|
Lin et al. (2020) |
Methylmercury | Pregnant mothers | Not applicable | Human (recruited from Greenville, South Carolina), n = 17 | Females | Microbial richness (α- and β-diversity) was not markedly changed for gut microbiota with high and low concentrations of mercury in hair and stool |
|
Rothenberg et al. (2016) |
Methylmercury | Pregnant mothers | Not applicable | Humans (recruited from only from South Caroline) | Females | Not applicable |
|
Rothenberg et al. (2019) |
Methylmercury | Adult |
|
|
|
|
|
Bridges et al. (2018) |
Methylmercury | Adult, 8 weeks old |
|
Sprague Dawley rats | Males |
|
|
Liu et al. (2019) |
Methylmercury | Adults, 18–80 years old | Subjects were asked to consume 3 fish meals per week for 2 weeks | Human (recruited from the University of Rochester Medical Center community, n = 37) |
|
Not applicable |
|
Caito et al. (2018) |
Monomethylmercury | Not applicable | 10 ng/g | In vitro experiment with human fecal samples (n = 2) | Not specified | Not applicable |
|
Guo et al. (2018) |
Mercuric chloride (HgCl2) | Chicks, 1 day old | 0 or 150 ppm in drinking water for 30, 60, and 90 days | Hyline chicken | Male | Day 30 results:
|
|
Zhou et al. (2020) |
Mercuric chloride | Adult, 8 weeks old | 0 or 2 mg/kg bw HgCl2 for 90 days | Kunming mice | Female |
|
|
Ruan et al. (2019) |
Abbreviations: As, arsenic; Cd, cadmium; IMT, intima-media thickness; MeHg, methylmercury; MgCl2, mercuric chloride; MMHg, monomethylmercury; PAH, polycyclic aromatic hydrocarbons: Pb, lead; WT, wildtype.
Exposures to cadmium altered the gut microbiota in frogs (Ya et al., 2019), fish (Chang et al., 2019), and mice (Breton et al., 2013, Zhang et al., 2015b) (Table 4). However, whether there are sex-specific changes remains to be determined because previous in vivo studies either did not examine sex differences or used only male or female animals.
Exposure to arsenic and its impact on the gut microbiome have been studied in mice and humans. Arsenic exposure has been shown to alter the gut microbiota in various strains of mice during neonatal, juvenile, and adult stages (Table 4). These alterations were also associated with changes in the metabolism of lipids, vitamin E, bile acids, oxidative stress, and detoxification. Arsenic exposure also presents a problem in humans through ingestion of contaminated waters. An adult human study in a Bangladesh population reported that arsenic exposure altered the gut microbiome and resulted in an overproduction of genus Citrobacter (Wu et al., 2019). Depending on the species, Citrobacter can result in various health problems such as urinary tract infections, respiratory diseases, inflamed gastrointestinal tract, and sepsis in immunocompromised individuals. Analysis showed a significant association between arsenic exposure in water, Citrobacter, and vascular intima-media thickness (IMT). IMT is accessed by measuring the distance of the luminal-intima to the medial-adventitia of the carotid artery by ultrasound. High IMT increases risk of developing cardiovascular diseases, specifically atherosclerosis. Ultimately, IMT is used as a subclinical marker for atherosclerosis (Simova, 2015). Thus, the data on arsenic exposure suggest that the altered gut microbiome may play an essential role in the development of atherosclerosis, possibly through a microbiota-derived metabolite called trimethylamine N-oxide (TMAO) (Jonsson and Bäckhed, 2017; Lindskog Jonsson et al., 2018). TMAO disrupts bile acid synthesis and metabolism, which is associated with atherosclerosis due to the buildup of cholesterol (Ding et al., 2018). Overall, having a stable microbiome, which includes the presence of Faecalibacterium, may reduce arsenic toxicity and arsenic-related diseases (Coryell et al., 2018).
The effects of mercury exposure on the microbiome have been studied in various species including mice, rats, chickens, fish, and humans during the adult stage (Table 4). The forms of mercury included in this literature review are the following: methylmercury (MeHg), monomethylmercury (MMHg), and mercuric chloride (MgCl2). Exposure to MeHg damaged the GI tract and altered the gut microbiota and its metabolites (Bridges et al., 2018, Lin et al., 2020). However, nutrition may provide some protection from MeHg toxicities. For example, supplementation of selenium reversed some changes in the gut microbiota of MeHg-poisoned rats so that the gut microbiota presented more like the control group (Liu et al., 2019). Protein addition also seems to enhance MMHg metabolism in vitro (Guo et al., 2018). Similar to MeHg, MgCl2 damaged the GI tract and resulted in thickened muscle walls, decreased goblet cells, widened submucosa, and necrotic enterocytes in the cecum of mice and chickens (Ruan et al., 2019; Zhou et al., 2020). In addition to changes in the morphology of the cecum and cecal microbiome, MgCl2 exposure was associated with altered metabolism of vitamin C, aldarate, xenobiotics, and PAHs (Zhou et al., 2020).
Although a myriad of studies have examined the effects of heavy metals on the gut microbiome, many of these microbiome studies only reported descriptive changes in the makeup of the gut microbiota and used only 1 type of sex or combined both sexes in their analyses (Table 4). In the future, it is important to conduct research beyond characterizing the gut microbiota to evaluate the effects of heavy metals on other aspects of health, such as metabolism and reproduction. Experiments that are designed to investigate the sex-dependent effects and multigenerational or transgenerational effects as a result of heavy metal exposure are especially important.
PESTICIDES AND THE GUT MICROBIOME
Pesticides, which include insecticides, herbicides, and fungicides, are used globally to aid in food production. Although pesticides are generally highly toxic to target species through mechanisms that may not affect humans and most nontarget species, many pesticides are toxic to humans and wildlife through other mechanisms, including endocrine disruption (Mnif et al., 2011). Recent studies on environmentally relevant doses of pesticides have revealed the long-term consequences of the environmental metabolites of legacy pesticides (Liang et al., 2019; Liu et al., 2016) as well as the harms of their replacements, especially on nontarget organ systems including the gut. As scientists are beginning to understand the complex functions of the gut microbiome, the literature on the effects of pesticides on gut microbiota has significantly expanded in the past 3 years (Table 5).
Table 5.
Chemical | Exposure Window | Dose | Model | Sex & Sex Differences | Effect on Gut Microbiota | Conclusions | References |
---|---|---|---|---|---|---|---|
Aldicarb (I) | Adult | 2 ppm (approximately 0.3 mg/kg bw/day) in drinking water for 13 weeks beginning at 8 weeks of age | C57BL/6 mice | Male |
|
|
Gao et al. (2019) |
Aminomethylphosphonic acid (AMPA; glyphosate metabolite) | Adult | 1.5 or 7.5 mM in sugar syrup or cotreatment with equal amounts of AMPA and glyphosate for 15 days | Honeybee | Female | None |
|
Blot et al. (2019) |
Atrazine (H) | Developmental | 200 µg/l in water environment for 6 days or in ex vivo culture of whole gut for 6 days | Cuban tree frog | Male and female, but sex differences not discussed | None |
|
Knutie et al. (2018) |
Adult | 1.0 µg/l atrazine dose (0.42 µg/l measured) in water environment starting at 4.5 months of age for 7 days | Zebrafish | Both; yes |
|
|
Chen et al. (2018b) | |
Azoxystrobin (F) | Adult | 0.1–5 mg/kg azoxystrobin in dry soil environment for 28 days | Enchytraeus crypticus | Not discussed |
|
|
Zhang et al. (2019a) |
Carbendazim (F) | Adult | 100 or 500 mg/kg orally via diet for 4 weeks starting at 7 weeks of age | ICR mice | Male |
|
|
Jin et al. (2015) |
Adult | 0.2–5 mg/kg orally via drinking water for 14 weeks starting at 6 weeks of age | C57BL/6 mice | Male |
|
|
Jin et al. (2018) | |
Chlorothalonil (F) | Adult | Chlorothalonil: 10 µg/l in 30% sucrose solution for 6 weeks | Honeybees | Both; however, sex differences were not assessed as both sexes were combined for analyses | ↓ Lactobacillaceae |
|
Kakumanu et al. (2016) |
Chlorpyrifos (I) | Developmental | 1 mg/kg bw/day by oral gavage from GD 0 to PND 21 (dams) and PND 21–60 (pups) | Hannover Wistar rats | Male (unclear) |
|
|
Joly et al. (2013) |
Developmental | 1 or 5 mg/kg bw/day by oral gavage from GD 0 to PND 21 (dams) and PND 21–60 (pups) | Wistar rats | Male |
|
|
Joly Condette et al. (2015) | |
Developmental | 1 or 3.5 mg/kg gavage to dams from GD 1 until PND 21, gavage to pups from PND 21 to 60; inulin cotreatment | Wistar rats | Male | ↓ Firmicutes, Clostridium coccoides (CPF only) |
|
Reygner et al. (2016a) | |
Adult | 0.3 mg/kg by gavage daily 25 weeks starting at 4 weeks of age or 20 weeks starting at 9 weeks of age with normal- or high-fat diet | Wistar rats | Male | Effects varies for all treatment groups |
|
Liang et al. (2019) | |
Adult | 0.3 or 3 mg/kg by gavage daily for 9 weeks starting at 9 weeks of age with normal- or high-fat diet | Wistar rats | Male |
|
|
Fang et al. (2018) | |
Adult | 1 mg/kg by gavage daily for 30 days beginning at 12 weeks of age | Chinese Kunming mice | Male |
|
|
Zhao et al. (2016) | |
Adult | 30–100 µg/l in water environment for 21 days | Zebrafish | Male | ↓ Proteobacteria |
|
Li et al. (2019a) | |
Adult | 5 mg/kg by gavage daily at 4 weeks of age for 12 weeks with normal- or high-fat diet | C57BL/6 and CD-1 (ICR) mice | Male |
|
|
Liang et al. (2019) | |
In vitro | 1 mg per day for 30 days | SHIME | Not applicable |
|
|
Joly et al. (2013) | |
In vitro | 3.5 mg/day injection in media into SHIME reactor for 30 days; cells treated with SHIME supernatant for 6 or 24 h; inulin cotreatment | SHIME and Caco-2/TC7 human intestinal cells | Not applicable | ↓ Lactobacillus, Bifidobacterium |
|
Réquilé et al. (2018) | |
In vitro | 1 mg/day in oil to SHIME for 30 days | SHIME human in vitro | Not applicable |
|
|
Reygner et al. (2016a) | |
Coumaphos (I) | Adult | Treated strips following manufacturer’s instructions for 6 weeks | Honeybees | Males and females were used; however, sex differences were not assessed because both sexes were combined for analyses | ↑ Burkholderiales, Bifidobacteriales |
|
Kakumanu et al. (2016) |
Adult | 650 µg/kg in sugar syrup for 24–34 h of interior worker bees | Honeybees | Female | ↓ Lactobacillus, Bifidobacterium |
|
Rouzé et al. (2019) | |
Diazinon (I) | Adult | 4 mg/l in drinking water for 13 weeks starting at 8 weeks of age | C57BL/6 mice |
|
|
|
Gao et al. (2017b) |
Adult | 4 mg/l in drinking water for 13 weeks starting at 8 weeks of age | C57BL/6 mice | Male | N/A |
|
Gao et al. (2017a) | |
Diethyl phosphate (metabolite of CPF + others) (I) | Adult | 0.08 or 0.13 mg/kg by gavage daily for 20 weeks starting at 8 weeks of age | Wistar rats | Male | ↑ Paraprevotella, Parabacteroides, Alloprevotella, Helicobacter |
|
Yang et al. (2019a) |
Epoxiconazole (F) | Adult | 4 or 100 mg/kg via diet for 90 days starting at 9 weeks of age | Sprague Dawley rats | Female |
|
|
Xu et al. (2014) |
Fipronil (I) | Adult | 0.25 or 1.0 µg/kg in sugar syrup for 24–34 h of interior worker bees | Honeybees | Female |
|
|
Rouzé et al. (2019) |
Glyphosate-based herbicide (GBH) | Developmental | 5 mg/kg/day oral dose via biscuits daily from GD 10 to PND 22 (weaning) | Sprague Dawley rats | Female |
|
|
Dechartres et al. (2019) |
Developmental | 1.75 mg/kg bw/day in drinking water to dams from GD 6 through weaning (PND 28); pups dosed in drinking water following weaning for 6 or 13 weeks | Sprague Dawley rats | Both; however, sex differences were not assessed because both sexes were combined for analyses |
|
|
Mao et al. (2018) | |
Adult | 250 or 500 mg/kg bw/day dose by gavage beginning at 1 month of age for 1 day, 6 weeks, or 12 weeks | Swiss mice | Male |
|
|
Aitbali et al. (2018) | |
Adult | 0.00022 to 3.6 g/l in cultured bacteria from caecum of wild turtles | Hawaiian green turtles | Both; however, sex differences were not assessed because both sexes were combined for analyses | ↓ Pantoea, Proteus, Shigella, Staphylococcus |
|
Kittle et al. (2018) | |
Adult |
|
Sprague Dawley rats |
|
|
|
Lozano et al. (2018) | |
In vitro | Bacterial strains from rat feces were treated with 0.1 ppb, 400 ppm, or 5000 ppm in media for 24 h | Sprague Dawley rats | Not applicable | ↓ Bifidobacteria, Clostridia, Enterococci (male, highest 2 doses) |
|
Lozano et al. (2018) | |
In vitro | 0.075–5 mg/ml in media for up to 5 days | Many bacterial strains from poultry | Not applicable |
|
|
Shehata et al. (2013) | |
Glyphosate (H) | Developmental | 0.8, 4, and 20 mg/l in diet from days 2 to 5 after grafting (larval stage) | Honeybees | Both; however, sex differences were not assessed because both sexes were combined for analyses | ↑ Firmicutes, Clostridia, γ-Proteobacteria, Clostridiales, Lachnospiraceae, Prevotellaceae, and Ruminococcaceae |
|
Dai et al. (2018) |
Developmental | 5 mg/kg/day oral dose via biscuits daily from GD 10 to PND 22 (weaning) | Sprague Dawley rats | Female |
|
|
Dechartres et al. (2019) | |
Developmental | 1.75 mg/kg bw/day in drinking water to dams from GD 6 through weaning (PND 28); pups dosed in drinking water following weaning for 6 or 13 weeks | Sprague Dawley rats | Both; however, sex differences were not assessed because both sexes were combined for analyses |
|
|
Mao et al. (2018) | |
Adult | 5 or 10 mg/l for 5 days of adult workers; 1 mM for 2 days or 0.1 mM for 5 days of newly hatched workers | Honeybees | Female |
|
|
Motta et al. (2018) | |
Adult | 1.5 or 7.5 mM in sugar syrup for 15 days; infection with parasite | Honeybees | Female |
|
|
Blot et al. (2019) | |
In vitro | 1, 10, 100 µg/ml in rumen fluid cultured in DAISY incubators for 48 h | Nonlactating Holstein-Friesian cow rumen fluid | Not applicable | ↓ Entodinium spp., Diplodinium spp., Epidinium spp., Ophryoscolex spp., Dasytricha spp. |
|
Ackermann et al. (2015) | |
Hexachlorocyclohexane (HCH, all isomers) (I) | Colostrum samples collected from eastern China | Human breast milk | Not applicable |
|
|
Tang et al. (2019) | |
β-Hexachlorocyclohexane (I) | Adult | 10 mg/kg daily by gavage for 8 weeks | C57BL/6 mice | Male |
|
|
Liu et al. (2017) |
Imazalil (F) | Adult | 100 or 1000 µg/l for 1, 7, or 21 days in aquatic environment at 6 months of age | Zebrafish | Male |
|
|
Jin et al. (2017) |
Adult | 0.1, 0.5, or 2.5 mg/kg bw/day orally via diet for 2, 5, or 15 weeks beginning at 6 weeks of age | C57BL/6 mice | Male | ↓ Bacteroidetes |
|
Jin et al. (2018) | |
Adult | 25, 50, or 100 mg/kg bw/day orally via diet for 4 weeks beginning at 6 weeks of age | ICR mice | Male | ↓ Bacteroidetes, Firmicutes, Actinobacteria |
|
Jin et al. (2016) | |
Imidacloprid (I) | Adult | 3.5 µg/kg in sugar syrup for 24–34 h to interior worker bees | Honeybees | Female | ↓ Lactobacillus, Bifidobacterium |
|
Rouzé et al. (2019) |
Adult | 500 µg/l in sugar syrup for 3 days to worker bees | Honeybees | Female | None |
|
Raymann et al. (2018) | |
Adult | 10–100 µM in food (length of treatment not given) | Drosophila melanogaster | Female | ↑ Acetobacter, Lactobacillus |
|
Daisley et al. (2017) | |
Malathion (I) | Adult | 2 mg/l ( approximately 0.6 mg/kg BW/day) in drinking water for 13 weeks beginning at 8 weeks of age | C57BL/6 mice | Male |
|
|
Gao et al. (2018a) |
Monocrotophos (I) | Adult | 28 µg/kg bw/day in drinking water for 180 days starting at 8 weeks of ages followed by fecal transplantation | BALB/c mice | Female | N/A |
|
Velmurugan et al. (2017) |
p,p′-Dichlorodiphenyldichloroethylene (metabolite of DDT, DDE) (I) | Adult | 1 mg/kg bw/day daily by gavage for 8 weeks | C57BL/6 mice | Male |
|
|
Liu et al. (2017) |
Adult | 2 mg/kg bw/day by gavage for 8 weeks beginning at 4 weeks of age; cotreatment and recovery with pectin | C57BL/6J mice | Male |
|
|
Zhan et al. (2019) | |
Pentachlorophenol (I, H) | Juvenile | 1, 50, or 100 µg/l in water environment for 28 days | Goldfish | Both; however, sex differences were not assessed because both sexes were combined for analyses |
|
|
Kan et al. (2015) |
Permethrin (I) | Juvenile | 34 mg/kg body weight gavage from PND 6 to 21, 4-month follow-up period | Wistar rats | Male | ↑ Lactobacillus, Bacteroides, Prevotella, Porphyromonas (PND 21, 51) |
|
Nasuti et al. (2016) |
In vitro | 3.2–0.00625 mg/ml in culture media | Many bacterial strains | Not applicable | N/A |
|
Nasuti et al. (2016) | |
Propamocarb (F) | Adult | 3–300 mg/l in drinking water (0.5–50 mg/kg bw/day) for 28 days starting at 6 weeks of age | ICR mice | Male |
|
|
Wu et al. (2018a) |
Adult | 1–10 mg/l in drinking water for 10 weeks beginning at 6 weeks of age | C57BL/6J mice | Male |
|
|
Wu et al. (2018b) | |
Adult | 100 and 1000 µg/l in water environment for 7 days | Zebrafish | Male | ↑ Proteobacteria, Bacteroidetes, Firmicutes (1000 µg) |
|
Zhang et al. (2019b) | |
Tau-fluvalinate (I) | Adult | Treated strips following manufacturer’s instructions for 6 weeks | Honeybees | Male and female; sex differences not assessed because both sexes were combined for analyses | ↓Enterobacteriaceae, Caulobacteraceae |
|
Kakumanu et al. (2016) |
Thiamethoxam (I) | Adult | 1.7 µg/kg in sugar syrup for 24–34 h of interior worker bees | Honeybees | Female |
|
|
Rouzé et al. (2019) |
Trichlorfon (I) | Adult | 12 µg/g bw single dose by oral gavage at 8 weeks of age, collected 24 h after dosing | Japanese quail |
|
|
|
Crisol-Martinez et al. (2016) |
Abbreviations: F, fungicide; H, herbicide; I, insecticide; SCFA, short-chain fatty acid; SHIME, Simulator of the Human Intestinal Microbial Ecosystem.
Both pure glyphosate and various glyphosate-based herbicide (GBH) formulations alter the bacterial makeup of the gut microbiome in rodents (Aitbali et al., 2018; Dechartres et al., 2019; Lozano et al., 2018; Mao et al., 2018) and honeybees (Blot et al., 2019; Dai et al., 2018; Motta et al., 2018). In contrast, aminomethylphosphonic acid (AMPA), a glyphosate metabolite, does not alter the gut microbiome of exposed honeybees (Blot et al., 2019). Collectively, these studies suggest that the parent compounds—not the metabolites—are responsible for the changes in the gut microbiome.
Extensive evidence indicates that the organophosphate chlorpyrifos affects microbial populations in male rodents and fish exposed during development and adulthood (Condette et al., 2015; Li et al., 2019a; Liang et al., 2019; Reygner et al., 2016b; Stunes et al., 2017). Chlorpyrifos exposure additionally causes inflammation and oxidative stress in the gut (Li et al., 2019a; Liang et al., 2019; Zhao et al., 2016). However, information on the effects of chlorpyrifos in females is lacking.
Few studies have examined the developmental effects of pesticide exposures beyond glyphosate and chlorpyrifos on the gut. However, studies in adults across multiple species using a wide range of insecticides, fungicides, and herbicides show alterations of the gut microbiome as well as other common effects, including altered lipid metabolism, inflammation, and oxidative stress (Table 5). The few studies that directly measured sex differences found differential alterations of gut microbiome between male and female animals following exposure to atrazine (Chen et al., 2018b), diazinon (Gao et al., 2017b), GBH (Lozano et al., 2018), and trichlorfon (Crisol-Martinez et al., 2016). However, there is disagreement on whether males or females have more alterations in the gut microbiome.
FUTURE DIRECTIONS
Collectively, the existing data suggest that exposure to environmental chemicals during various stages of life causes alterations in the gut microbiome and is associated with changes in health, including immune dysfunction, altered carbohydrate and lipid metabolism, and neurobehavioral impairments. Moreover, the effects of the environmental chemicals on gut microbiota highly depend on sex and age. A major question raised from the studies reviewed is whether, and to what extent, microbiota mediate the disease-causing effects of the environmental chemicals. The field of gut microbiome toxicology is still relatively new, which is why many studies have only reported changes in the gut microbiota composition and not on the mechanisms by which chemicals interfere with gut microbiota. In the future, it is important to characterize which microbes are present by sequencing the full length of 16S rRNA gene to correctly identify strains and species that are in the gut. A partial 16S rRNA sequencing, commonly on hypervariable regions 3 and 4 (V3 and V4), does not yield enough depth to give information on the species or strains of microbes. While partial 16S rRNA sequencing can give us some information on changes at higher taxonomic levels, this information is not enough because different strains of the same species can have different effects. For example, Escherichia coli O157: H7 is a disease-causing strain whereas E. coli Nissle 1917 is a probiotic strain (Wassenaar, 2016). In addition to identifying changes of gut bacteria at the species and strain levels, studies should also include metagenomic sequencing to study alterations of other microorganisms in the gut microbiome, which would provide insights into the functional changes in the gut microbiome. On the whole, future studies should examine the causal relationship between chemically induced changes in the gut microbiome and chemically induced adverse health outcomes. As such, research should supplement sequencing studies with mechanistic studies using conventional and gnotobiotic animal models, such as fish, mice, and pigs, because these models are essential for understanding the impact of environmental chemicals on the gut microbiome and the health consequences resulting from the altered gut microbiota (Nguyen et al., 2015).
FUNDING
National Institute of Environmental Health Sciences (NIH T32 ES007326, NIH R01 ES028661), UIUC Division of Nutritional Sciences (Vision 20/20), and UIUC College of Veterinary Medicine.
DECLARATION OF CONFLICTING INTERESTS
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
REFERENCES
- Ackermann W., Coenen M., Schrödl W., Shehata A. A., Krüger M. (2015). The influence of glyphosate on the microbiota and production of botulinum neurotoxin during ruminal fermentation. Curr. Microbiol. 70, 374–382. [DOI] [PubMed] [Google Scholar]
- Aitbali Y., Ba-M'hamed S., Elhidar N., Nafis A., Soraa N., Bennis M. (2018). Glyphosate based-herbicide exposure affects gut microbiota, anxiety and depression-like behaviors in mice. Neurotoxicol. Teratol. 67, 44–49. [DOI] [PubMed] [Google Scholar]
- Babich M. A., Osterhout C. A. (2010). Toxicity Review of Diisononyl Phthalate (DINP). United States Consumer Product Safety Commission, Bethesda, MD. [Google Scholar]
- Baxter N. T., Zackular J. P., Chen G. Y., Schloss P. D. (2014). Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome 2, 20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blot N., Veillat L., Rouze R., Delatte H. (2019). Glyphosate, but not its metabolite AMPA, alters the honeybee gut microbiota. PLoS One 14, e0215466. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bourassa M. W., Alim I., Bultman S. J., Ratan R. R. (2016). Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health? Neurosci. Lett. 625, 56–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breton J., Massart S., Vandamme P., De Brandt E., Pot B., Foligné B. (2013). Ecotoxicology inside the gut: Impact of heavy metals on the mouse microbiome. BMC Pharmacol. Toxicol. 14, 62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bridges K. N., Zhang Y., Curran T. E., Magnuson J. T., Venables B. J., Durrer K. E., Allen M. S., Roberts A. P. (2018). Alterations to the intestinal microbiome and metabolome of pimephales promelas and Mus musculus following exposure to dietary methylmercury. Environ. Sci. Technol. 52, 8774–8784. [DOI] [PubMed] [Google Scholar]
- Caito S. W., Jackson B. P., Punshon T., Scrimale T., Grier A., Gill S. R., Love T. M., Watson G. E., van Wijngaarden E., Rand M. D. (2018). Editor’s highlight: Variation in methylmercury metabolism and elimination status in humans following fish consumption. Toxicol. Sci. 161, 443–453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Catron T. R., Keely S. P., Brinkman N. E., Zurlinden T. J., Wood C. E., Wright J. R., Phelps D., Wheaton E., Kvasnicka A., Gaballah S., et al. (2019). Host developmental toxicity of BPA and BPA alternatives is inversely related to microbiota disruption in zebrafish. Toxicol. Sci. 167, 468–483. [DOI] [PubMed] [Google Scholar]
- Center for Disease Control. (2017). Biomonitoring Program Activities: Environmental Chemicals National Biomonitoring Program. Available at: https://www.cdc.gov/biomonitoring/environmental_chemicals.html. Accessed November 1, 2019.
- Chang X., Li H., Feng J., Chen Y., Nie G., Zhang J. (2019). Effects of cadmium exposure on the composition and diversity of the intestinal microbial community of common carp (Cyprinus carpio L.). Ecotoxicol. Environ. Saf. 171, 92–98. [DOI] [PubMed] [Google Scholar]
- Chen L., Lam J., Hu C., Tsui M. M. P., Wang Q., Giesy J. P., Lam P. (2018. a). Perfluorobutanesulfonate exposure causes durable and transgenerational dysbiosis of gut microbiota in marine medaka. Environ. Sci. Technol. Lett. 5, 731–738. [Google Scholar]
- Chen L., Zhang W., Hua J., Hu C., Lok-Shun Lai N., Qian P. Y., Lam P. K. S., Lam J. C. W., Zhou B. (2018. b). Dysregulation of intestinal health by environmental pollutants: Involvement of the estrogen receptor and aryl hydrocarbon receptor. Environ. Sci. Technol. 52, 2323–2330. [DOI] [PubMed] [Google Scholar]
- Chi L., Bian X., Gao B., Ru H., Tu P., Lu K. (2016). Sex-specific effects of arsenic exposure on the trajectory and function of the gut microbiome. Chem. Res. Toxicol. 29, 949–951. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chi L., Bian X., Gao B., Tu P., Ru H., Lu K. (2017). The effects of an environmentally relevant level of arsenic on the gut microbiome and its functional metagenome. Toxicol. Sci. 160, 193–204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chi L., Xue J., Tu P., Lai Y., Ru H., Lu K. (2019). Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice. Arch. Toxicol. 93, 25–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chiang C., Flaws J. A. (2019). Subchronic exposure to di(2-ethylhexyl) phthalate and diisononyl phthalate during adulthood has immediate and long-term reproductive consequences in female mice. Toxicol. Sci. 168, 620–631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi J. J., Eum S. Y., Rampersaud E., Daunert S., Abreu M. T., Toborek M. (2013). Exercise attenuates PCB-induced changes in the mouse gut microbiome. Environ. Health Perspect. 121, 725–730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins S. M., Surette M., Bercik P. (2012). The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 10, 735–742. [DOI] [PubMed] [Google Scholar]
- Condette C. J., Bach V., Mayeur C., Gay-Queheillard J., Khorsi-Cauet H. (2015). Chlorpyrifos exposure during perinatal period affects intestinal microbiota associated with delay of maturation of digestive tract in rats. J. Pediatr. Gastroenterol. Nutr. 61, 30–40. [DOI] [PubMed] [Google Scholar]
- Correa-Oliveira R., Fachi J. L., Vieira A., Sato F. T., Vinolo M. A. (2016). Regulation of immune cell function by short-chain fatty acids. Clin. Transl. Immunol. 5, e73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coryell M., McAlpine M., Pinkham N. V., McDermott T. R., Walk S. T. (2018). The gut microbiome is required for full protection against acute arsenic toxicity in mouse models. Nat. Commun. 9, 1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cresci G. A., Bawden E. (2015). Gut microbiome: What we do and don’t know. Nutr. Clin. Pract. 30, 734–746. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crisol-Martinez E., Moreno-Moyano L. T., Wilkinson N., Prasai T., Brown P. H., Moore R. J., Stanley D. (2016). A low dose of an organophosphate insecticide causes dysbiosis and sex-dependent responses in the intestinal microbiota of the Japanese quail (Coturnix japonica). PeerJ 4, e2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dai P., Yan Z., Ma S., Yang Y., Wang Q., Hou C., Wu Y., Liu Y., Diao Q. (2018). The herbicide glyphosate negatively affects midgut bacterial communities and survival of honey bee during larvae reared in vitro. J. Agric. Food Chem. 66, 7786–7793. [DOI] [PubMed] [Google Scholar]
- Daisley B. A., Trinder M., McDowell T. W., Welle H., Dube J. S., Ali S. N., Leong H. S., Sumarah M. W., Reid G. (2017). Neonicotinoid-induced pathogen susceptibility is mitigated by Lactobacillus plantarum immune stimulation in a Drosophila melanogaster model. Sci. Rep. 7, 2703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dechartres J., Pawluski J. L., Gueguen M. M., Jablaoui A., Maguin E., Rhimi M., Charlier T. D. (2019). Glyphosate and glyphosate-based herbicide exposure during the peripartum period affects maternal brain plasticity, maternal behaviour and microbiome. J. Neuroendocrinol. 31, e12731. [DOI] [PubMed] [Google Scholar]
- Defois C., Ratel J., Garrait G., Denis S., Le Goff O., Talvas J., Mosoni P., Engel E., Peyret P. (2018). Food chemicals disrupt human gut microbiota Activity and impact intestinal homeostasis as revealed by in vitro systems. Sci. Rep. 8, 11006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dheer R., Patterson J., Dudash M., Stachler E. N., Bibby K. J., Stolz D. B., Shiva S., Wang Z., Hazen S. L., Barchowsky A., et al. (2015). Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism. Toxicol. Appl. Pharmacol. 289, 397–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ding L., Chang M., Guo Y., Zhang L., Xue C., Yanagita T., Zhang T., Wang Y. (2018). Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 17, 286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EFSA. (2012). Perfluoroalkylated substances in food: Occurrence and dietary exposure. Eur. Food Saf. Authority J. 10, 55. [Google Scholar]
- Fang B., Li J. W., Zhang M., Ren F. Z., Pang G. F. (2018). Chronic chlorpyrifos exposure elicits diet-specific effects on metabolism and the gut microbiome in rats. Food Chem. Toxicol. 111, 144–152. [DOI] [PubMed] [Google Scholar]
- Gao B., Bian X., Chi L., Tu P., Ru H., Lu K. (2017. a). Organophosphate diazinon altered quorum sensing, cell motility, stress response, and carbohydrate metabolism of gut microbiome. Toxicol. Sci. 157, 354–364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao B., Bian X., Mahbub R., Lu K. (2017. b). Sex-specific effects of organophosphate diazinon on the gut microbiome and its metabolic functions. Environ. Health Perspect. 125, 198–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao B., Chi L., Mahbub R., Bian X., Tu P., Ru H., Lu K. (2017. c). Multi-omics Reveals That Lead Exposure Disturbs Gut Microbiome Development, Key Metabolites and Metabolic Pathways Chem. Res. Toxicol 30, 996–1005. [DOI] [PMC free article] [PubMed]
- Gao B., Chi L., Tu P., Bian X., Thomas J., Ru H., Lu K. (2018. a). The organophosphate Malathion disturbs gut microbiome development and the quorum-Sensing system. Toxicol. Lett. 283, 52–57. [DOI] [PubMed] [Google Scholar]
- Gao B., Chi L., Tu P., Gao N., Lu K. (2019). The carbamate aldicarb altered the gut microbiome, metabolome, and lipidome of C57BL/6J mice. Chem. Res. Toxicol. 32, 67–79. [DOI] [PubMed] [Google Scholar]
- Gao J., Xu K., Liu H., Liu G., Bai M., Peng C., Li T., Yin Y. (2018. b). Impact of the Gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell. Infect. Microbiol. 8, 13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaulke C. A., Rolshoven J., Wong C. P., Hudson L. G., Ho E., Sharpton T. J. (2018). Marginal zinc deficiency and environmentally relevant concentrations of arsenic elicit combined effects on the gut microbiome. mSphere 3, e00521–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gokulan K., Arnold M. G., Jensen J., Vanlandingham M., Twaddle N. C., Doerge D. R., Cerniglia C. E., Khare S. (2018). Exposure to arsenite in CD-1 mice during juvenile and adult stages: Effects on intestinal microbiota and gut-associated immune status. mBio 9, 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guan Y., Zhang T., He J., Jia J., Zhu L., Wang Z. (2019). Bisphenol A disturbed the lipid metabolism mediated by sterol regulatory element binding protein 1 in rare minnow Gobiocypris rarus. Aquat. Toxicol. 207, 179–186. [DOI] [PubMed] [Google Scholar]
- Guo G., Yumvihoze E., Poulain A. J., Man Chan H. (2018). Monomethylmercury degradation by the human gut microbiota is stimulated by protein amendments. J. Toxicol. Sci. 43, 717–725. [DOI] [PubMed] [Google Scholar]
- Guo X., Liu S., Wang Z., Zhang X.-X., Li M., Wu B. (2014). Metagenomic profiles and antibiotic resistance genes in gut microbiota of mice exposed to arsenic and iron. Chemosphere 112, 1–8. [DOI] [PubMed] [Google Scholar]
- Hannon P. R., Flaws J. A. (2015). The effects of phthalates on the ovary. Front. Endocrinol. (Lausanne) 6, 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hu J., Raikhel V., Gopalakrishnan K., Fernandez-Hernandez H., Lambertini L., Manservisi F., Falcioni L., Bua L., Belpoggi F., Teitelbaum S., et al. (2016). Effect of postnatal low-dose exposure to environmental chemicals on the gut microbiome in a rodent model. Microbiome 4, 26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jaishankar M., Tseten T., Anbalagan N., Mathew B. B., Beeregowda K. N. (2014). Toxicity, mechanism and health effects of some heavy metals. Interdiscip. Toxicol. 7, 60–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Javurek A. B., Spollen W. G., Johnson S. A., Bivens N. J., Bromert K. H., Givan S. A., Rosenfeld C. S. (2016). Effects of exposure to bisphenol A and ethinyl estradiol on the gut microbiota of parents and their offspring in a rodent model. Gut Microbes 7, 471–485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ji J., Qu H. (2019). Cross-regulatory circuit between AhR and microbiota. Curr. Drug Metab. 20, 4–8. [DOI] [PubMed] [Google Scholar]
- Jin C., Luo T., Zhu Z., Pan Z., Yang J., Wang W., Fu Z., Jin Y. (2017). Imazalil exposure induces gut microbiota dysbiosis and hepatic metabolism disorder in zebrafish. Comp. Biochem. Physiol. Toxicol. Pharmacol. 202, 85–93. [DOI] [PubMed] [Google Scholar]
- Jin C., Zeng Z., Fu Z., Jin Y. (2016). Oral imazalil exposure induces gut microbiota dysbiosis and colonic inflammation in mice. Chemosphere 160, 349–358. [DOI] [PubMed] [Google Scholar]
- Jin C., Zeng Z., Wang C., Luo T., Wang S., Zhou J., Ni Y., Fu Z., Jin Y. (2018). Insights into a possible mechanism underlying the connection of carbendazim-induced lipid metabolism disorder and gut microbiota dysbiosis in mice. Toxicol. Sci. 166, 382–393. [DOI] [PubMed] [Google Scholar]
- Jin Y., Zeng Z., Wu Y., Zhang S., Fu Z. (2015). Oral exposure of mice to carbendazim induces hepatic lipid metabolism disorder and gut microbiota dysbiosis. Toxicol. Sci. 147, 116–126. [DOI] [PubMed] [Google Scholar]
- Joly C., Gay-Queheillard J., Leke A., Chardon K., Delanaud S., Bach V., Khorsi-Cauet H. (2013). Impact of chronic exposure to low doses of chlorpyrifos on the intestinal microbiota in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in the rat. Environ. Sci. Pollut. Res. Int. 20, 2726–2734. [DOI] [PubMed] [Google Scholar]
- Joly Condette C., Bach V., Mayeur C., Gay-Quéheillard J., Khorsi-Cauet H. (2015). Chlorpyrifos exposure during perinatal period affects intestinal microbiota associated with delay of maturation of digestive tract in rats. J. Pediatr. Gastroenterol. Nutr. 61, 30–40. [DOI] [PubMed] [Google Scholar]
- Jonsson A. L., Bäckhed F. (2017). Role of gut microbiota in atherosclerosis. Nat. Rev. Cardiol. 14, 79–87. [DOI] [PubMed] [Google Scholar]
- Kakumanu M. L., Reeves A. M., Anderson T. D., Rodrigues R. R., Williams M. A. (2016). Honey bee gut microbiome is altered by in-hive pesticide exposures. Front. Microbiol. 7, 1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kan H., Zhao F., Zhang X.-X., Ren H., Gao S. (2015). Correlations of gut microbial community shift with hepatic damage and growth inhibition of Carassius auratus induced by pentachlorophenol exposure. Environ. Sci. Technol. 49, 11894–11902. [DOI] [PubMed] [Google Scholar]
- Kinch C. D., Ibhazehiebo K., Jeong J. H., Habibi H. R., Kurrasch D. M. (2015). Low-dose exposure to bisphenol A and replacement bisphenol S induces precocious hypothalamic neurogenesis in embryonic zebrafish. Proc. Natl. Acad. Sci. U.S.A. 112, 1475–1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kittle R. P., McDermid K. J., Muehlstein L., Balazs G. H. (2018). Effects of glyphosate herbicide on the gastrointestinal microflora of Hawaiian green turtles (Chelonia mydas) Linnaeus. Mar. Pollut. Bull. 127, 170–174. [DOI] [PubMed] [Google Scholar]
- Knutie S. A., Gabor C. R., Kohl K. D., Rohr J. R. (2018). Do host-associated gut microbiota mediate the effect of an herbicide on disease risk in frogs? J. Anim. Ecol. 87, 489–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koestel Z. L., Backus R. C., Tsuruta K., Spollen W. G., Johnson S. A., Javurek A. B., Ellersieck M. R., Wiedmeyer C. E., Kannan K., Xue J., et al. (2017). Bisphenol A (BPA) in the serum of pet dogs following short-term consumption of canned dog food and potential health consequences of exposure to BPA. Sci. Total Environ. 579, 1804–1814. [DOI] [PubMed] [Google Scholar]
- Kolb S. A., O'Loughlin E. J., Gsell T. C. (2019). Characterization of phthalate-degrading bacteria from Asian carp microbiomes and riverine sediments. Int. Biodeterior. Biodegradation 143, 104727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lefever D. E., Xu J., Chen Y., Huang G., Tamas N., Guo T. L. (2016). TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice. Toxicol. Appl. Pharmacol. 304, 48–58. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lei M., Menon R., Manteiga S., Alden N., Hunt C., Alaniz R. C., Lee K., Jayaraman A. (2019). Environmental chemical diethylhexyl phthalate alters intestinal microbiota community structure and metabolite profile in mice. mSystems 4, e00724–00719. [DOI] [PMC free article] [PubMed]
- Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070–11075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ley R. E., Turnbaugh P. J., Klein S., Gordon J. I. (2006). Human gut microbes associated with obesity. Nature 444, 1022–1023. [DOI] [PubMed] [Google Scholar]
- Li J.-W., Fang B., Pang G.-F., Zhang M., Ren F.-Z. (2019. a). Age- and diet-specific effects of chronic exposure to chlorpyrifos on hormones, inflammation and gut microbiota in rats. Pestic. Biochem. Physiol. 159, 68–79. [DOI] [PubMed] [Google Scholar]
- Li Q., Loganath A., Chong Y. S., Tan J., Obbard J. (2006). Persistent organic pollutants and adverse health effects in humans. J. Toxicol. Environ. Health A 69, 1987–2005. [DOI] [PubMed] [Google Scholar]
- Li X., Brejnrod A. D., Ernst M., Rykær M., Herschend J., Olsen N. M. C., Dorrestein P. C., Rensing C., Sørensen S. J. (2019. b). Heavy metal exposure causes changes in the metabolic health-associated gut microbiome and metabolites. Environ. Int. 126, 454–467. [DOI] [PubMed] [Google Scholar]
- Liang Y., Zhan J., Liu D., Luo M., Han J., Liu X., Liu C., Cheng Z., Zhou Z., Wang P. (2019). Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota. Microbiome 7, 19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin X., Zhao J., Zhang W., He L., Wang L., Chang D., Cui L., Gao Y., Li B., Chen C., et al. (2020). Acute oral methylmercury exposure perturbs the gut microbiome and alters gut-brain axis related metabolites in rats. Ecotoxicol. Environ. Saf. 190, 110130. [DOI] [PubMed] [Google Scholar]
- Lindskog Jonsson A., Caesar R., Akrami R., Reinhardt C., Fåk Hållenius F., Borén J., Bäckhed F. (2018). Impact of gut microbiota and diet on the development of atherosclerosis in ApoE−/− mice. Arterioscler. Thromb. Vasc. Biol. 38, 2318–2326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu Q., Shao W., Zhang C., Xu C., Wang Q., Liu H., Sun H., Jiang Z., Gu A. (2017). Organochloride pesticides modulated gut microbiota and influenced bile acid metabolism in mice. Environ. Pollut. 226, 268–276. [DOI] [PubMed] [Google Scholar]
- Liu Y., Ji J., Zhang W., Suo Y., Zhao J., Lin X., Cui L., Li B., Hu H., Chen C., et al. (2019). Selenium modulated gut flora and promoted decomposition of methylmercury in methylmercury-poisoned rats. Ecotoxicol. Environ. Saf. 185, 109720. [DOI] [PubMed] [Google Scholar]
- Liu Y., Yao Y., Li H., Qiao F., Wu J., Du Z. Y., Zhang M. (2016). Influence of endogenous and exogenous estrogenic endocrine on intestinal microbiota in zebrafish. PLoS One 11, e0163895. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lozano V. L., Defarge N., Rocque L.-M., Mesnage R., Hennequin D., Cassier R., de Vendômois J. S., Panoff J.-M., Séralini G.-E., Amiel C. (2018). Sex-dependent impact of Roundup on the rat gut microbiome. Toxicol. Rep. 5, 96–107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu K., Abo R. P., Schlieper K. A., Graffam M. E., Levine S., Wishnok J. S., Swenberg J. A., Tannenbaum S. R., Fox J. G. (2014. a). Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: An integrated metagenomics and metabolomics analysis. Environ. Health Perspect. 122, 284–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lu K., Mahbub R., Cable P. H., Ru H., Parry N. M. A., Bodnar W. M., Wishnok J. S., Styblo M., Swenberg J. A., Fox J. G., et al. (2014. b). Gut microbiome phenotypes driven by host genetics affect arsenic metabolism. Chem. Res. Toxicol. 27, 172–174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malaise Y., Menard S., Cartier C., Gaultier E., Lasserre F., Lencina C., Harkat C., Geoffre N., Lakhal L., Castan I., et alet al. (2017). Gut dysbiosis and impairment of immune system homeostasis in perinatally-exposed mice to bisphenol A precede obese phenotype development. Sci. Rep. 7, 14472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Malaise Y., Menard S., Cartier C., Lencina C., Sommer C., Gaultier E., Houdeau E., Guzylack-Piriou L. (2018). Consequences of bisphenol a perinatal exposure on immune responses and gut barrier function in mice. Arch. Toxicol. 92, 347–358. [DOI] [PubMed] [Google Scholar]
- Mao Q., Manservisi F., Panzacchi S., Mandrioli D., Menghetti I., Vornoli A., Bua L., Falcioni L., Lesseur C., Chen J., et al. (2018). The Ramazzini Institute 13-week pilot study on glyphosate and Roundup administered at human-equivalent dose to Sprague Dawley rats: Effects on the microbiome. Environ. Health 17, 50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin A. M., Sun E. W., Rogers G. B., Keating D. J. (2019). The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Front. Physiol. 10, 428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mnif W., Hassine A. I., Bouaziz A., Bartegi A., Thomas O., Roig B. (2011). Effect of endocrine disruptor pesticides: A review. Int. J. Environ. Res. Pub. Health 8, 2265–2303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motta E. V. S., Raymann K., Moran N. A. (2018). Glyphosate perturbs the gut microbiota of honey bees. Proc. Natl. Acad. Sci. U.S.A. 115, 10305–10310. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nagy K., Tessema R. A., Budnik L. T., Adam B. (2019). Comparative cyto- and genotoxicity assessment of glyphosate and glyphosate-based herbicides in human peripheral white blood cells. Environ. Res. 179, 108851. [DOI] [PubMed] [Google Scholar]
- Naito Y., Uchiyama K., Takagi T. (2018). A next-generation beneficial microbe: Akkermansia muciniphila. J. Clin. Biochem. Nutr. 63, 33–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nasuti C., Coman M. M., Olek R. A., Fiorini D., Verdenelli M. C., Cecchini C., Silvi S., Fedeli D., Gabbianelli R. (2016). Changes on fecal microbiota in rats exposed to permethrin during postnatal development. Environ. Sci. Pollut. Res. Int. 23, 10930–10937. [DOI] [PubMed] [Google Scholar]
- Nguyen T. L. A., Vieira-Silva S., Liston A., Raes J. (2015). How informative is the mouse for human gut microbiota research? Dis. Models Mech. 8, 1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicholson J. K., Holmes E., Kinross J., Burcelin R., Gibson G., Jia W., Pettersson S. (2012). Host-gut microbiota metabolic interactions. Science 336, 1262–1267. [DOI] [PubMed] [Google Scholar]
- Olsen G. W., Mair D. C., Lange C. C., Harrington L. M., Church T. R., Goldberg C. L., Herron R. M., Hanna H., Nobiletti J. B., Rios J. A., et al. (2017). Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000–2015. Environ. Res. 157, 87–95. [DOI] [PubMed] [Google Scholar]
- Pan Z., Yuan X., Tu W., Fu Z., Jin Y. (2019). Subchronic exposure of environmentally relevant concentrations of F-53B in mice resulted in gut barrier dysfunction and colonic inflammation in a sex-independent manner. Environ. Pollut. 253, 268–277. [DOI] [PubMed] [Google Scholar]
- Parada Venegas D., De la Fuente M. K., Landskron G., Gonzalez M. J., Quera R., Dijkstra G., Harmsen H. J. M., Faber K. N., Hermoso M. A. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 10, 277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patisaul H. B. (2020). Achieving CLARITY on bisphenol A, brain and behaviour. J. Neuroendocrinol. 32, e12730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Petriello M. C., Hoffman J. B., Vsevolozhskaya O., Morris A. J., Hennig B. (2018). Dioxin-like PCB 126 increases intestinal inflammation and disrupts gut microbiota and metabolic homeostasis. Environ. Pollut. 242, 1022–1032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qi W., Clark J. M., Timme-Laragy A. R., Park Y. (2018). Perfluorobutanesulfonic acid (PFBS) potentiates adipogenesis of 3T3-L1 adipocytes. Food Chem. Toxicol. 120, 340–345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qu W., Zhao Z., Chen S., Zhang L., Wu D., Chen Z. (2018). Bisphenol A suppresses proliferation and induces apoptosis in colonic epithelial cells through mitochondrial and MAPK/AKT pathways. Life Sci. 208, 167–174. [DOI] [PubMed] [Google Scholar]
- Raymann K., Motta E. V. S., Girard C., Riddington I. M., Dinser J. A., Moran N. A. (2018). Imidacloprid decreases honey bee survival rates but does not affect the gut microbiome. Appl. Environ. Microbiol. 84, e00545–00518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reddivari L., Veeramachaneni D. N. R., Walters W. A., Lozupone C., Palmer J., Hewage M. K. K., Bhatnagar R., Amir A., Kennett M. J., Knight R., et al. (2017). Perinatal bisphenol A exposure induces chronic inflammation in rabbit offspring via modulation of gut bacteria and their metabolites. mSystems 2, e00093–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Réquilé M., Gonzàlez Alvarez D. O., Delanaud S., Rhazi L., Bach V., Depeint F., Khorsi-Cauet H. (2018). Use of a combination of in vitro models to investigate the impact of chlorpyrifos and inulin on the intestinal microbiota and the permeability of the intestinal mucosa. Environ. Sci. Pollut. Res. Int. 25, 22529–22540. [DOI] [PubMed] [Google Scholar]
- Reygner J., Joly Condette C., Bruneau A., Delanaud S., Rhazi L., Depeint F., Abdennebi-Najar L., Bach V., Mayeur C., Khorsi-Cauet H. (2016. a). Changes in composition and function of human intestinal microbiota exposed to chlorpyrifos in oil as assessed by the SHIME(®) model. Int. J. Environ. Res. Pub. Health 13, 1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reygner J., Lichtenberger L., Elmhiri G., Dou S., Bahi-Jaber N., Rhazi L., Depeint F., Bach V., Khorsi-Cauet H., Abdennebi-Najar L. (2016. b). Inulin supplementation lowered the metabolic defects of prolonged exposure to chlorpyrifos from gestation to young adult stage in offspring rats. PLoS One 11, e0164614. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rochester J. R. (2013). Bisphenol A and human health: A review of the literature. Reprod. Toxicol. 42, 132–155. [DOI] [PubMed] [Google Scholar]
- Rochester J. R., Bolden A. L. (2015). Bisphenol S and F: A systematic review and comparison of the hormonal activity of bisphenol A substitutes. Environ. Health Perspect. 123, 643–650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rothenberg S. E., Keiser S., Ajami N. J., Wong M. C., Gesell J., Petrosino J. F., Johs A. (2016). The role of gut microbiota in fetal methylmercury exposure: Insights from a pilot study. Toxicol. Lett. 242, 60–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rothenberg S. E., Wagner C. L., Hamidi B., Alekseyenko A. V., Andrea Azcarate-Peril M. (2019). Andrea Azcarate-Peril M. 2019. Longitudinal changes during pregnancy in gut microbiota and methylmercury biomarkers, and reversal of microbe-exposure correlations. Environ. Res. 172, 700–712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rouzé R., Moné A., Delbac F., Belzunces L., Blot N. (2019). The honeybee gut microbiota is altered after chronic exposure to different families of insecticides and infection by Nosema ceranae. Microbes Environ. 34, 226–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ruan Y., Wu C., Guo X., Xu Z., Xing C., Cao H., Zhang C., Hu G., Liu P. (2019). High doses of copper and mercury changed cecal microbiota in female mice. Biol. Trace Elem. Res. 189, 134–144. [DOI] [PubMed] [Google Scholar]
- Rude K. M., Pusceddu M. M., Keogh C. E., Sladek J. A., Rabasa G., Miller E. N., Sethi S., Keil K. P., Pessah I. N., Lein P. J., et al. (2019). Developmental exposure to polychlorinated biphenyls (PCBs) in the maternal diet causes host-microbe defects in weanling offspring mice. Environ. Pollut. 253, 708–721. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Samuel B. S., Gordon J. I. (2006). A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc. Natl. Acad. Sci. 103, 10011–10016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scoville D. K., Li C. Y., Wang D., Dempsey J. L., Raftery D., Mani S., Gu H., Cui J. Y. (2019). Polybrominated diphenyl ethers and gut microbiome modulate metabolic syndrome-related aqueous metabolites in mice. Drug Metab. Dispos. 47, 928–940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shehata A. A., Schrödl W., Aldin A. A., Hafez H. M., Krüger M. (2013). The effect of glyphosate on potential pathogens and beneficial members of poultry microbiota in vitro. Curr. Microbiol. 66, 350–358. [DOI] [PubMed] [Google Scholar]
- Simova I. (2015). Intima-media thickness: Appropriate evaluation and proper measurement, described. Eur. Soc. Cardiol. 13, 21. [Google Scholar]
- Siwen W., Huang J., Yang Y., Hui Y., Ge Y., Larssen T., Yu G., Deng S., Wang B., Harman C. (2013). First report of a Chinese PFOS alternative overlooked for 30 years: Its toxicity, persistence, and presence in the environment. Environ. Sci. Technol. 47, 10163–10170. [DOI] [PubMed] [Google Scholar]
- Stedtfeld R. D., Brett Sallach J., Crawford R. B., Stedtfeld T. M., Williams M. R., Waseem H., Johnston C. T., Li H., Teppen B. J., Kaminski N. E., et al. (2017. a). TCDD administered on activated carbon eliminates bioavailability and subsequent shifts to a key murine gut commensal. Appl. Microbiol. Biotechnol. 101, 7409–7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stedtfeld R. D., Chai B., Crawford R. B., Stedtfeld T. M., Williams M. R., Xiangwen S., Kuwahara T., Cole J. R., Kaminski N. E., Tiedje J. M., et al. (2017. b). Modulatory influence of segmented filamentous bacteria on transcriptomic response of gnotobiotic mice exposed to TCDD. Front. Microbiol. 8, 1708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stedtfeld R. D., Stedtfeld T. M., Fader K. A., Williams M. R., Bhaduri P., Quensen J., Zacharewski T. R., Tiedje J. M., Hashsham S. A. (2017. c). TCDD influences reservoir of antibiotic resistance genes in murine gut microbiome. FEMS Microbiol. Ecol. 93, fix058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stunes A. K., Syversen U., Berntsen S., Paulsen G., Stea T. H., Hetlelid K. J., Lohne-Seiler H., Mosti M. P., Bjørnsen T., Raastad T., et al. (2017). High doses of vitamin C plus E reduce strength training-induced improvements in areal bone mineral density in elderly men. Eur. J. Appl. Physiol. 117, 1073–1084. [DOI] [PubMed] [Google Scholar]
- Sweeney T. E., Morton J. M. (2013). The human gut microbiome. JAMA Surg. 148, 563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sze M. A., Schloss P. D. (2016). Looking for a signal in the noise: Revisiting obesity and the microbiome. mBio 7, e01018–01016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang M., Xu C., Chen K., Yan Q., Mao W., Liu W., Ritz B. (2019). Hexachlorocyclohexane exposure alters the microbiome of colostrum in Chinese breastfeeding mothers. Environ. Pollut. 254, 112900. [DOI] [PubMed] [Google Scholar]
- U.S. Environmental Protection Agency. (2018). Human Health Toxicity Values for Perfluorobutane Sulfonic Acid and Related Compound Potassium Perfluorobutane Sulfonate. Available at: https://www.epa.gov/sites/production/files/2018-11/documents/pfbs_public_comment_draft_toxicity_assessment_nov2018-508.pdf. [PubMed]
- Van de Wiele T., Vanhaecke L., Boeckaert C., Peru K., Headley J., Verstraete W., Siciliano S. (2005). Human colon microbiota transform polycyclic aromatic hydrocarbons to estrogenic metabolites. Environ. Health Perspect. 113, 6–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Velmurugan G., Ramprasath T., Swaminathan K., Mithieux G., Rajendhran J., Dhivakar M., Parthasarathy A., Babu D. D. V., Thumburaj L. J., Freddy A. J., et al. (2017). Gut microbial degradation of organophosphate insecticides-induces glucose intolerance via gluconeogenesis. Genome Biol. 18, 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vom Saal F. S., Nagel S. C., Coe B. L., Angle B. M., Taylor J. A. (2012). The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol. Cell. Endocrinol. 354, 74–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walter J. M., Bagi A., Pampanin D. M. (2019). Insights into the potential of the Atlantic cod gut microbiome as biomarker of oil contamination in the marine environment. Microorganisms 7, 209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang C., Yue S., Hao Z., Ren G., Lu D., Zhang Q., Zhao M. (2019. a). Pubertal exposure to the endocrine disruptor mono-2-ethylhexyl ester at body burden level caused cholesterol imbalance in mice. Environ. Pollut. 244, 657–666. [DOI] [PubMed] [Google Scholar]
- Wang C., Zhang Y., Deng M., Wang X., Tu W., Fu Z., Jin Y. (2019. b). Bioaccumulation in the gut and liver causes gut barrier dysfunction and hepatic metabolism disorder in mice after exposure to low doses of OBS. Environ. Int. 129, 279–290. [DOI] [PubMed] [Google Scholar]
- Wang D., Yan J., Teng M., Yan S., Zhou Z., Zhu W. (2018. a). In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: Impaired lipid metabolism and intestinal dysbiosis. Arch. Toxicol. 92, 1847–1860. [DOI] [PubMed] [Google Scholar]
- Wang K., Liao M., Zhou N., Bao L., Ma K., Zheng Z., Wang Y., Liu C., Wang W., Wang J., et al. (2019. c). Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 26, 222–235.e225. [DOI] [PubMed] [Google Scholar]
- Wang L., Wang Y., Liang Y., Li J., Liu Y., Zhang J., Zhang A., Fu J., Jiang G. (2015). PFOS induced lipid metabolism disturbances in BALB/c mice through inhibition of low density lipoproteins excretion. Sci. Rep. 4, 4582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang Y., Rui M., Nie Y., Lu G. (2018. b). Influence of gastrointestinal tract on metabolism of bisphenol A as determined by in vitro simulated system. J. Hazard. Mater. 355, 111–118. [DOI] [PubMed] [Google Scholar]
- Wassenaar T. M. (2016). Insights from 100 years of research with probiotic E. coli. Eur. J. Microbiol. Immunol. 6, 147–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weir T. L., Manter D. K., Sheflin A. M., Barnett B. A., Heuberger A. L., Ryan E. P. (2013). Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 8, e70803. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wittassek M., Koch H. M., Angerer J., Bruning T. (2011). Assessing exposure to phthalates—The human biomonitoring approach. Mol. Nutr. Food Res. 55, 7–31. [DOI] [PubMed] [Google Scholar]
- Wright D. P., Rosendale D. I., Roberton A. M. (2000). Prevotellaenzymes involved in mucin oligosaccharide degradation and evidence for a small operon of genes expressed during growth on mucin. FEMS Microbiol. Lett. 190, 73–79. [DOI] [PubMed] [Google Scholar]
- Wu F., Yang L., Islam M. T., Jasmine F., Kibriya M. G., Nahar J., Barmon B., Parvez F., Sarwar G., Ahmed A., et al. (2019). The role of gut microbiome and its interaction with arsenic exposure in carotid intima-media thickness in a Bangladesh population. Environ. Int. 123, 104–113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu J., Wen X. W., Faulk C., Boehnke K., Zhang H., Dolinoy D. C., Xi C. (2016). Perinatal lead exposure alters gut microbiota composition and results in sex-specific bodyweight increases in adult mice. Toxicol. Sci. 151, 324–333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu S., Jin C., Wang Y., Fu Z., Jin Y. (2018. a). Exposure to the fungicide propamocarb causes gut microbiota dysbiosis and metabolic disorder in mice. Environ. Pollut. 237, 775–783. [DOI] [PubMed] [Google Scholar]
- Wu S., Luo T., Wang S., Zhou J., Ni Y., Fu Z., Jin Y. (2018. b). Chronic exposure to fungicide propamocarb induces bile acid metabolic disorder and increases trimethylamine in C57BL/6J mice. Sci. Total Environ. 642, 341–348. [DOI] [PubMed] [Google Scholar]
- Xu J., Huang G., Nagy T., Teng Q., Guo T. L. (2019). Sex-dependent effects of bisphenol A on type 1 diabetes development in non-obese diabetic (NOD) mice. Arch. Toxicol. 93, 997–1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu C., Liu Q., Huan F., Qu J., Liu W., Gu A., Wang Y., Jiang Z. (2014). Changes in gut microbiota may be early signs of liver toxicity induced by epoxiconazole in rats. Chemotherapy 60, 135–142. [DOI] [PubMed] [Google Scholar]
- Xue J., Lai Y., Chi L., Tu P., Leng J., Liu C.-W., Ru H., Lu K. (2019). Serum metabolomics reveals that gut microbiome perturbation mediates metabolic disruption induced by arsenic exposure in mice. J. Proteome Res. 18, 1006–1018. [DOI] [PubMed] [Google Scholar]
- Ya J., Ju Z., Wang H., Zhao H. (2019). Exposure to cadmium induced gut histopathological damages and microbiota alterations of Chinese toad (Bufo gargarizans) larvae. Ecotoxicol. Environ. Saf. 180, 449–456. [DOI] [PubMed] [Google Scholar]
- Yang F., Li J., Pang G., Ren F., Fang B. (2019. a). Effects of diethyl phosphate, a non-specific metabolite of organophosphorus pesticides, on serum lipid, hormones, inflammation, and gut microbiota. Molecules 24, 2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yang Y. N., Yang Y. S. H., Lin I. H., Chen Y. Y., Lin H. Y., Wu C. Y., Su Y. T., Yang Y. J., Yang S. N., Suen J. L. (2019. b). Phthalate exposure alters gut microbiota composition and IgM vaccine response in human newborns. Food Chem. Toxicol. 132, 110700. [DOI] [PubMed] [Google Scholar]
- Zhan J., Liang Y., Liu D., Ma X., Li P., Zhai W., Zhou Z., Wang P. (2019). Pectin reduces environmental pollutant-induced obesity in mice through regulating gut microbiota: A case study of p,p′-DDE. Environ. Int. 130, 104861. [DOI] [PubMed] [Google Scholar]
- Zhang L., Nichols R. G., Correll J., Murray I. A., Tanaka N., Smith P. B., Hubbard T. D., Sebastian A., Albert I., Hatzakis E., et al. (2015. a). Persistent organic pollutants modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation. Environ. Health Perspect. 123, 679–688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang P., Zhu W., Wang D., Yan J., Wang Y., Zhou Z., He L. (2017). A combined NMR- and HPLC-MS/MS-based metabolomics to evaluate the metabolic perturbations and subacute toxic effects of endosulfan on mice. Environ. Sci. Pollut. Res. Int. 24, 18870–18880. [DOI] [PubMed] [Google Scholar]
- Zhang Q., Zhu D., Ding J., Zheng F., Zhou S., Lu T., Zhu Y.-G., Qian H. (2019. a). The fungicide azoxystrobin perturbs the gut microbiota community and enriches antibiotic resistance genes in Enchytraeus crypticus. Environ. Int. 131, 104965. [DOI] [PubMed] [Google Scholar]
- Zhang R., Pan Z., Wang X., Shen M., Zhou J., Fu Z., Jin Y. (2019. b). Short-term propamocarb exposure induces hepatic metabolism disorder associated with gut microbiota dysbiosis in adult male zebrafish. Acta Biochim. Biophys. Sin. 51, 88–96. [DOI] [PubMed] [Google Scholar]
- Zhang S., Jin Y., Zeng Z., Liu Z., Fu Z. (2015. b). Subchronic exposure of mice to cadmium perturbs their hepatic energy metabolism and gut microbiome. Chem. Res. Toxicol. 28, 2000–2009. [DOI] [PubMed] [Google Scholar]
- Zhao Z., Qu W., Wang K., Chen S., Zhang L., Wu D., Chen Z. (2019). Bisphenol A inhibits mucin 2 secretion in intestinal goblet cells through mitochondrial dysfunction and oxidative stress. Biomed. Pharmacother. 111, 901–908. [DOI] [PubMed] [Google Scholar]
- Zhao F., Wang H., Wei P., Jiang G., Wang W., Zhang X., Ru S. (2018). Impairment of bisphenol F on the glucose metabolism of zebrafish larvae. Ecotoxicol. Environ. Saf. 165, 386–392. [DOI] [PubMed] [Google Scholar]
- Zhao Y., Zhang Y., Wang G., Han R., Xie X. (2016). Effects of chlorpyrifos on the gut microbiome and urine metabolome in mouse (Mus musculus). Chemosphere 153, 287–293. [DOI] [PubMed] [Google Scholar]
- Zhou C., Xu P., Huang C., Liu G., Chen S., Hu G., Li G., Liu P., Guo X. (2020). Effects of subchronic exposure of mercuric chloride on intestinal histology and microbiota in the cecum of chicken. Ecotoxicol. Environ. Saf. 188, 109920. [DOI] [PubMed] [Google Scholar]
- Ziv-Gal A., Flaws J. A. (2016). Evidence for bisphenol A-induced female infertility: A review (2007–2016). Fertil. Steril. 106, 827–856. [DOI] [PMC free article] [PubMed] [Google Scholar]